Author: acn

香港, 2025年8月25日 - (亚太商讯 via SeaPRwire.com) – 中国领先的技术驱动移动出行平台嘀嗒出行（"嘀嗒"或"公司"，股票代码：02559.HK）公布了截至2025年6月30日止六个月的经审计的综合年度业绩。财务亮点：- 截至2025年6月30日止六个月，收入为2.86亿元人民币，2024年同期为4.04亿元人民币。- 截至2025年6月30日止六个月，毛利润为1.92亿元人民币，2024年同期为2.96亿元人民币。- 截至2025年6月30日止六个月，净利润为1.34亿元人民币，2024年同期为9.48亿元人民币。- 截至2025年6月30日止六个月，调整后净利润（非国际财务报告准则计量）为1.36亿元人民币，相比2024年同期的1.30亿元人民币，增长4.7%。运营亮点：- 截至2025年6月30日止六个月，交易总额为26.08亿元人民币，订单总数达到4320万。- 截至2025年6月30日，注册用户超过3.95亿。- 注册私家车车主达到1990万。- 2025年上半年，嘀嗒出行的站点拼车顺风车订单量逐月增加。业务展望：顺风车业务嘀嗒顺风车平台上的乘客可以获得低成本的出行选择，并享受优质出行服务体验。私家车车主可以通过与乘客分担出行费用来节省油费和过路费。顺风车还能带来更多社会效益，例如减少碳排放和缓解交通拥堵等。嘀嗒出行认为，乘客选择顺风车的主要原因在于其价格优势，而车主的痛点则在于绕行成本。今年，我们持续优化站点车站顺风车模式，进一步减少车主的绕行距离并降低乘客车费。2025年上半年，站点拼车顺风车的订单量逐月增加。值得注意的是，合乘出行具有明显的线路特性。与网约车服务不同，车主与乘客间存在潜在的半熟人关系。今年上半年，嘀嗒出行持续强化车主乘客的半熟人互动机制，已取得初步成效。嘀嗒出行认为，相较于现行的上门接送模式，私家车车主在不绕行或尽量少绕行的情况下接送乘客，同时接受乘客以优惠车费支付，是更为合理的做法。与网约车服务的交易性质不同，顺风车模式中车主与乘客能建立更平等的互动关系，他们可能来自于相似的社会、经济或区域背景，未来，嘀嗒出行会持续挖掘此商业模式的独特属性，为用户提供更经济实惠、高效且公平的共乘体验。嘀嗒出行将持续优化平台用户体验。今年下半年计划推出聚合出行服务，与合规运力平台合作，解决未能匹配到顺风车车主的乘客的出行需求，以及其他即时出行需求，嘀嗒出行认为此举将进一步完善平台生态系统，强化服务能力。此外，嘀嗒出行平台吸引了近2000万私家车车主加入，今年计划与合作伙伴合作，为私家车车主提供更多售后服务，例如维修保养、融资、保险和二手车交易等服务。出租车业务在已经签订战略合作协议的选定城市，嘀嗒出行将继续携手所有利益相关方（包括地方部门、出租车行业协会、出租车公司和出租车司机），以推动动态定价解决方案。嘀嗒出行截至2026年6月30日止六个月的完整业绩公告，请访问： https://manager.wisdomir.com/files/594/2025/0822/20250822203001_24635760_tc.pdf关于嘀嗒出行嘀嗒出行（"嘀嗒"或"本公司"，股票代码：02559.HK）是中国领先的技术驱动出行平台。公司通过顺风车平台服务，连接路线方向相似且出发时间兼容的乘客与私家车主，从而创造了更多的交通容量，同时减少了对环境的影响。嘀嗒出行还提供智慧出租车服务，致力于提升中国出租车行业相关方的运营效能。嘀嗒致力于打造更绿色、高效的出行生态，让每一段旅程温暖而愉悦。前瞻性声明本新闻稿包含有关公司业务前景、预测业务计划和增长战略的前瞻性陈述。这些前瞻性陈述基于公司目前信息，并基于本新闻稿发布时的前景进行陈述。它们基于某些期望、假设和前提，其中一些是主观的或不可控的，可能被证明是不正确的，未来可能无法实现。前瞻性陈述背后存在大量风险和不确定性。有关这些风险和不确定性的更多信息，请参阅公司网站上的其他公开披露文件。 Copyright 2025 亚太商讯 via SeaPRwire.com.

HONG KONG, Aug 25, 2025 - (ACN Newswire via SeaPRwire.com) - Dida Inc. (“Dida” or the “Company”, Stock Code: 02559.HK), a leading technology-driven mobility platform, announced the audited consolidated annual results for the six months ended June 30, 2025.Financial Highlights:- Revenue was RMB 286.3 million for the six months ended June 30, 2025, compared to RMB 404.1 million for the six months ended June 30, 2024.- Gross profit was RMB191.8 million for the six months ended June 30, 2025,compared to RMB 296.1 million for the six months ended June 30, 2024.- Net profit was RMB134.3 million for the six months ended June 30, 2025,compared to RMB 947.9 million for the six months ended June 30, 2024.- Adjusted net profit (non-IFRS measure) increased by 4.7% from RMB129.7 million for the six months ended June 30, 2024 to RMB135.8 million for the six months ended June 30, 2025.Operation Highlights:- Gross transaction value amounted to RMB 2,608 million and total number of orders reached 43.2 million for the six months ended June 30, 2025.- Registered users reached over 395 million as of June 30, 2025.- Certified private car owners reached 19.9 million.- During the first half of 2025, the order volume for our station-based carpooling model increased month by month.Business OutlookCarpooling marketplace businessRiders on our carpooling platform can access low-cost mobility options and enjoy quality experience. Private car owners can save money on gas and tolls by sharing traveling expenseswith riders. Carpooling also brings about numerous societal benefits, such as reducing carbon emissions and mitigating traffic congestion.We believe the primary reason riders choose carpooling is its pricing, while the pain point for car owners is the cost of detours. This year, we continue to focus on optimizing our station-based carpooling model to further reduce detour distances for car owners and fares for riders. During the first half of 2025, the order volume for our station-based carpooling model increased month by month. It is also noteworthy that carpooling travel has distinct route specific characteristics. Unlike ride-hailing service, there is a potential semi-acquaintance relationship between drivers and riders. In the first half of this year, we experimented with enhancing these semi-acquaintance interactions between drivers and riders and achieved positive results.We believe that compared to the current door-to-door pickup model, It is more reasonable for private car owners to pick up passengers with no or minimum detour, while accept riders to pay at a discounted fare. Unlike the transactional nature of ride-hailing services, drivers and riders in carpooling lead to a more equal interaction. They may come from similar social,economic, or geographical backgrounds. In the future, we will continue to explore the unique characteristics of our business to provide users with an affordable, efficient and equitable ride-sharing experience.We will continue to enhance the user experience on our platform. In the second half of the year, we plan to work with ride-hailing platforms to address the needs of those carpooling riders who are not able to find matching private car owners and other on-demand travel needs. We believe this will enhance our platform’s ecosystem and service offerings.Additionally, our platform has attracted nearly 20 million private car owners. This year,we intend to collaborate with partners to provide private car owners with more aftermarket service offerings such as repair and maintenance, financing, insurance and used car trading.Taxi businessIn selected cities where we have already entered into strategic cooperation agreements, we continue to engage with all relevant stakeholders, including local authorities, taxi industry associations, taxi companies, and taxi drivers to implement dynamic pricing solutions.For the full announcement of Dida for the six months ended June 30, 2025, please visit:https://manager.wisdomir.com/files/594/2025/0822/20250822203001_23855082_en.pdfAbout Dida Inc.Dida Inc. (“Dida” or the “Company”, Stock Code: 02559.HK) is a leading technology-driven mobility platform in China. The Company creates more transit capacity with less environmental impact by providing carpooling marketplace services to pair up riders with private car owners if they are heading in similar directions at compatible times. It also provides smart taxi services, aiming to improve the efficacy and efficiency of relevant stakeholders in the taxi industry in China. Dida makes the mobility ecosystem greener and more efficient, and each trip experience warm and enjoyable.Forward-Looking StatementsThis press release contains forward-looking statements relating to the business outlook, forecast business plans and growth strategies of the Company. These forward-looking statements are based on information currently available to the Company and are stated herein on the basis of the outlook at the time of this press release. They are based on certain expectations, assumptions and premises, some of which are subjective or beyond the control. These forward-looking statements may prove to be incorrect and may not be realized in future. Underlying the forward-looking statements is a large number of risks and uncertainties. Further information regarding these risks and uncertainties is included in the other public disclosure documents on the corporate website. Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 25, 2025 - (ACN Newswire via SeaPRwire.com) - The Payment Cards Group Limited (“PCG”), a cloud-native payment processor and acquirer, continues to advance digital transformation and sustainable development in Hong Kong through innovative payment technologies. In July 2025, PCG and its subsidiaries Yedpay and BBMSL demonstrated their industry leadership at both international and local events by sharing insights on strategic partnerships, showcasing its innovative “SoftPOS” payment solution, and launching promotional offers with PayMe. These efforts help merchants enhance competitiveness and operational efficiency while driving industry transformation and supporting the development of a green economy.Pioneering green payment innovation: Yedpay “SoftPOS” empowers NFC-enabled smart devices as secure payment terminalsOn July 9, 2025, PCG’s digital payment acceptance business, Yedpay, introduced its groundbreaking digital payment solution, “SoftPOS,” at the Low Carbon Living Symposium 2025. Powered by PCG’s innovative technology, “SoftPOS” transforms any NFC-enabled smart device into a secure payment terminal, facilitating a cashless society while reducing hardware waste. Featuring bank-level encryption and PCI DSS compliance, “SoftPOS” delivers transaction security equivalent to traditional terminals while offering superior speed and adaptability. During the event, SUNMI collaborated with Yedpay to demonstrate a practical merchant implementation through integration with their Smart Desktop Terminal. In addition to minimizing hardware requirements, the seamless operations of “SoftPOS” enhances the one-tap payment functionality in the retail and F&B sectors and enables merchants to implement cashless payments within minutes. It also supports green lifestyle reward programs such as GreenCorner, further promoting sustainable consumption and commerce.PCG shares strategic partnership insights at MarTech Summit Hong Kong 2025On July 8, 2025, Andy Leung, former Marketing Director of PCG, spoke at the MarTech Summit Hong Kong 2025, a global marketing technology event. During the panel discussion themed “Collaborative Marketing - Unlocking Growth Through Strategic Partnerships,” he shared how PCG drives payment innovation and creates long-term value for businesses through cross-industry strategic collaboration. He highlighted the critical role of partnerships in enhancing brand competitiveness, building lasting customer relationships, and accelerating industry transformation. During the panel discussion, representatives from Shake Shack, Mox, a digital bank backed by Standard Chartered, and Jebsen Group also shared insights on strategic partnerships from their respective industry perspectives.BBMSL collaborates with PayMe to launch promotions, fostering market expansion for merchantsSince BBMSL, a payment solutions provider under PCG, became a payment acquirer for digital wallet, PayMe by HSBC, last year, the two companies have continued to strengthen their partnership. Recently, BBMSL teamed up with PayMe to launch promotions sponsored by PayMe for merchant partners, More Yogurt and Toys“R”Us:1.Chillout with PayMe! PayMe drink voucher* — Spend HK$30 or more with PayMe at any More Yogurt outlet (excluding Tai Po YATA store) and receive a HK$3 discount on your entire transaction. Offer valid until October 31, 2025.2.Toys“R”Us Instant Discount Offer* — Spend HK$500 or more with PayMe at Toys"R"Us and receive a HK$20 discount on your entire transaction. Offer valid until August 31, 2025.BBMSL aims to leverage these promotions to help merchants drive sales and deepen customer engagement in today’s challenging consumer market, thereby enhancing brand value. Beyond its continued focus on payment innovation, PCG and its subsidiaries are committed to fostering digital transformation and sustainable development across industries through strategic partnerships and data-driven marketing, creating shared success for merchants, consumers, and the environment. *Please refer to the PayMe app for promotion details, terms, and conditions,About Payment Cards Group (“PCG”)The Payment Cards Group Limited (“PCG”) is an innovative and leading payment technology company with operations in Singapore, Hong Kong and the Asia-Pacific region. Established in 2016, PCG has become an acquirer with principal memberships in all major card schemes and e-wallet networks. Yedpay, a member of PCG, has firmly established itself as a digital payment acceptance business in Hong Kong. Meanwhile, A3A, another member of PCG, has developed a cloud-native payment processing platform that operates through RESTful APIs, significantly reducing costs and streamlining complex processes while providing users with real-time transaction data and insights. As an acquiring processor, PCG serves as the backbone infrastructure of the entire payment industry by its Asia’s 1st cloud-based processing and settlement platform. Rooted in Hong Kong with a global vison, PCG seeks to empower merchants with cutting-edge payment technology solutions and drive high-quality development in the global payment ecosystem. For more information, please visit PCG’s website: https://www.yedpay.com/en/For media enquiries, please contact:AJA (IR and Communications)Avy YuTel: (852) 9500 4443Email: avy.yu@ajacapital.com.hk / info@ajacapital.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - August 21, 2025) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce that as a result of strong investor demand, the Company has increased the size of its previously announced "bought deal" public offering (the "Underwritten Offering") from gross proceeds of approximately C$5,000,000 to gross proceeds of approximately C$6,000,000. Pursuant to the upsized Underwritten Offering, Red Cloud Securities Inc. ("Red Cloud"), as sole underwriter and bookrunner, has agreed to purchase for resale 6,666,667 units of the Company (each, a "Unit") at a price of C$0.90 per Unit (the "Offering Price").Each Unit will consist of one common share of the Company (each, a "Unit Share") and one common share purchase warrant (each, a "Warrant"). Each Warrant shall entitle the holder to purchase one common share of the Company (each, a "Warrant Share") at a price of C$1.35 at any time on or before that date which is 36 months after the Closing Date (as herein defined).The Company has granted to the Underwriter an option (the "Over-Allotment Option", and together with the Underwritten Offering, the "Offering"), exercisable, in whole or in part, at any time for a period of up to 30 days after and including the Closing Date, to purchase for resale the number of additional Units equal to up to 15% of the number of Units sold pursuant to the Underwritten Offering at the Offering Price to cover over allotments, if any, and for market stabilization purposes.The net proceeds from the Offering will be used by the Company to fund ongoing operations including, but not limited to, commercial development, product development and working capital. In connection with the Offering, the Company intends to file a prospectus supplement (the "Supplement") to the Company's final short form base shelf prospectus dated March 7, 2025 (the "Shelf Prospectus"), with the securities regulatory authorities in each of the provinces and territories of Canada, except Quebec. The Units may also be sold in the United States on a private placement basis pursuant to one or more exemptions from the registration requirements of the United States Securities Act of 1933, as amended (the "U.S. Securities Act") and in such other jurisdictions outside of Canada and the United States, in each case in accordance with all applicable laws provided that no prospectus, registration statement or similar document is required to be filed in such jurisdiction, and provided the issuance of the Units (including the underlying securities) is permitted under laws applicable to the Company (including the Australian Corporations Act 2001 (Cth).Copies of the Shelf Prospectus and the Supplement to be filed in connection with the Offering, can be found on SEDAR+ at www.sedarplus.ca. The Shelf Prospectus contains, and the Supplement will contain, important detailed information about the Company and the Offering. Prospective investors should read the Supplement, the Shelf Prospectus and the other documents the Company has filed on SEDAR+ at www.sedarplus.ca before making an investment decision.The Offering is expected to close on or about September 3, 2025 (the "Closing Date"), or on such date as agreed upon between the Company and Red Cloud. The closing of the Offering is subject to the Company receiving all necessary regulatory approvals, including the approval of the TSX Venture Exchange to list, on the Closing Date, the common shares of the Company issuable from the sale of Units as well as upon the exercise of the Warrants.This press release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the U.S. Securities Act, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.About GMGGMG is an Australian-based clean-technology company, which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in-house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low-cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy saving coating), which is now being marketed into other applications, including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed to improve the performance of lithium ion batteries.GMG's 4 critical business objectives are:Produce Graphene and Improve/Scale Cell Production ProcessesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking StatementsThis news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding the expected size and terms of the Offering, the anticipated timing of closing the Offering, the ability of the Company to satisfy all conditions to closing the Offering, and the expected use of proceeds from the Offering.Such forward-looking statements are based on a number of assumptions of management, including, without limitation, expectations and assumptions concerning the business objectives of the Company; the Company's ability to carry out current planned capital projects, research and development, manufacturing, production, sales and marketing programs for its graphene and graphene-enhanced products and solutions; that the Company will receive the necessary regulatory approvals for the Offering; use the proceeds from the Offering as anticipated; the Company's performance and general business and economic conditions.Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: the risk that the Company is not able to use the proceeds from the Offering as anticipated by management; the risk that the Company does not receive the requisite regulatory approvals for the Offering; overall economic conditions; technical de-risking and market acceptance for the Company's products and solutions; the introduction of competing technologies or products; stock market volatility; environmental and regulatory requirements; competitive pressures; change in market conditions and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied in these forward-looking statements; the volatility of global capital markets; political instability; the failure of the Company to obtain regulatory approvals, attract and retain skilled personnel; unexpected development and production challenges; unanticipated costs and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated October 3, 2024 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws.NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/263313 Copyright 2025 ACN Newswire via SeaPRwire.com.

香港, 2025年8月22日 - (亚太商讯 via SeaPRwire.com) – 中信资源控股有限公司（"中信资源"或"公司"，连同其附属公司统称为"集团"；股份代号：1205.HK）于截至2025年6月30日止六个月（"期内"），坚定执行"投资+贸易"双轮驱动发展战略。在面对大宗商品价格持续下行、能源行业承受严峻经营压力下，集团仍展现出较强的经营韧性。未来，集团将继续深化双轮驱动发展模式，全力拓展油气贸易业务，并重点布局铝产品产业链投资，从全方位提升企业价值。集团积极应对大宗商品价格波动带来的不利影响，部署多项应对举措，油气业务方面，深化增储上产、开源节流各项措施，挖掘资源潜力，加大提质增效力度，提升市场价值；非油气业务，则按照"控股必控制、参股必行权"的原则，提升参与项目管理的频度和深度，向作业方传递降本增效的经营建议。期内，得益于油气贸易业务稳步扩大规模，集团实现营业收入约93.8亿港元，同比大幅增长约137.9%。受原油及煤炭价格持续下跌、原料氧化铝价格高企等因素影响，归母净利润约1.5亿港元（2024年上半年：约3.5亿港元）。尽管如此，集团半数分部及投资于期内录得溢利，继续维持稳健的财务状况，于2025年6月30日的现金及存款约44.2亿港元（2024年12月31日：20.3亿港元）。截至2025年6月30日，集团总资产约159.3亿港元，归母净资产约76.6亿港元，资产负债率约51.0%，年化股东权益回报率约3.9%，集团资产状况健康，流动性充裕。中信资源执行董事、主席兼行政总裁郝维宝先生表示："油气仍将在能源结构中占据关键地位，而发展中国家和新兴经济体持续的工业化、城镇化进程将继续支撑电解铝需求，新能源、电动汽车及高端装备制造等领域的快速发展也将进一步拉动铝消费增长。集团将延续‘稳中求进’的策略，坚定不移地深化‘投资+贸易’双轮驱动发展战略，在巩固现有业务高质量发展根基的同时，稳健开拓油气贸易业务版图，重点布局以铝产品为核心的中上游矿业投资和优质油气开发项目投资。通过全面提升项目运营效能、优化市值管理体系、强化全面风险管控，持续夯实企业核心竞争力，集团将以稳健的经营策略和创新的发展理念，不断提升企业价值，为股东创造持续、稳定的投资回报。"有关中信资源2025年中期业绩的详情，请参考集团在香港联交所及其网站的中期业绩公告。关于中信资源控股有限公司（股份代号：1205.HK）中信资源控股有限公司自1997年起，在香港联合交易所上市。中信资源的主要业务包括石油和煤的勘探、开发和生产，于铝土矿开采、氧化铝冶炼和电解铝领域的投资及油气贸易。中国中信股份有限公司持有中信资源约59.5%的股权，为中信资源最大股东。 Copyright 2025 亚太商讯 via SeaPRwire.com.

财务摘要︰- 2025年上半年收益为人民币634.3百万元，较2024年同期大幅增长44.4%。其中，综合游戏发行及运营业务收益同比增长53.8%至人民币579.0百万元，占总收益的91.3%。- 2025年上半年毛利为人民币452.8百万元，较2024年同期大幅增长40.8%，毛利率为71.4%，与去年同期保持基本一致。- 2025年上半年研发开支同比增长0.5%至人民币265.5百万元。销售及营销开支同比上涨28.7%至人民币222.3百万元，主要由于《踏风行》于报告期内在中国大陆上线，以及《龙族：卡塞尔之门》持续产生的推广及广告开支所致，这被《以闪亮之名》因进入稳定运营阶段而缩减的广告开支所部分抵销。- 2025年上半年经调整亏损净额较2024年上半年同比收窄93.6%至人民币7.7百万元。营运摘要︰ - 祖龙娱乐专注于开发优质MMORPG、女性向、策略卡牌、SLG及其他类型的手游。截至2025年中期业绩公告发布之日，集团在逾170个地区市场推出24款精品手游，支持14种语言的多个地区版本。 - 超自由时尚女性向手游《以闪亮之名》自2023年3月上线中国大陆地区以来，十余次以强劲之姿跻身中国大陆iOS游戏畅销榜前十名。截至2025年中期业绩公告发布之日，全球累计流水超过20亿元。 - 《龙族：卡塞尔之门》作为策略卡牌类游戏的佳作，自中国大陆地区上线以来收获到各界广泛认可和好评。游戏分别于2025年4月及2025年8月在中国大陆地区、中国港澳台地区及东南亚地区正式上线，获得优异的游戏畅销榜和免费榜成绩。 - 放置RPG手游《踏风行》于2025年5月在中国大陆地区正式上线，预下载当日即登顶iOS游戏免费榜榜首。 - 经典游戏《龙族幻想》、《梦幻诛仙》等仍在持续进行运营投入，游戏表现稳定并为集团持续贡献收益，其中《梦幻诛仙》2025年上半年流水和新增用户量逆势双增。- 为打造多品类及风格多样的游戏组合，集团预期于2025年下半年至2027年期间在全球各地推出7款不同类型的游戏产品，其中包括一款融合国风和卡通美学的回合制MMORPG游戏项目代号：逍遥，一款基于知名IP改编、以西方奇幻题材为背景的策略卡牌游戏项目G，以及一款依托虚幻引擎5 制作的女性向游戏项目K。香港, 2025年8月22日 - (亚太商讯 via SeaPRwire.com) - 祖龙娱乐有限公司（"祖龙娱乐"或"公司"，连同其附属公司，统称"集团"，股份代号：9990.HK）公布其截至2025年6月30日止六个月（"报告期内"）之未经审核中期业绩。2025年上半年，祖龙娱乐录得收益人民币634.3百万元，较截至2024年同期人民币439.4百万元大幅增加44.4%，主要由于《龙族：卡塞尔之门》和《踏风行》分别于2024年下半年和2025年上半年在中国大陆上线，及《以闪亮之名》的持续稳定表现所致；其中，综合游戏发行及运营业务收益为人民币579.0百万元，较2024年同期增加53.8%，占总收益的91.3%。2025年上半年，集团毛利同比大幅增加40.8%至人民币452.8百万元；毛利率为71.4%，与去年同期保持基本一致。报告期内，集团研发开支同比增长0.5%至人民币265.5百万元。销售及营销开支同比上涨28.7%至人民币222.3百万元，主要由于《踏风行》于报告期内在中国大陆上线，以及《龙族：卡塞尔之门》持续产生的推广及广告开支所致，这被《以闪亮之名》因进入稳定运营阶段而缩减的广告开支所部分抵销。综合上述因素，2025年上半年集团经调整亏损净额为人民币7.7百万元，较2024年同期大幅收窄93.6%。《以闪亮之名》长线运营策略获市场验证 两款新游上线带动流水增长《以闪亮之名》是一款以公司新一代女性制作和策划团队为核心研发的超自由时尚女性向手游，自2023年3月上线中国大陆地区以来，十余次以强劲之姿跻身iOS游戏畅销榜前十名。随着研发和运营效率的提升，继2025年1月份的单月利润创下游戏上线后的历史新高后，2025年上半年的利润同比和环比均实现了显著的增长。游戏推出了全球代言人荔枝喵，依托大语言模型为玩家带来有温度的情感陪伴。游戏于2025年7月更新的版本"踏歌神飨"主题曲《母神傩》在B站上线三天内的浏览量超300万，并上线多个音乐平台，获得了玩家们的高度关注。此外，在陆续推出的活动中，游戏与欢乐谷、《甄嬛传》、故宫宫苑、饿了么等开展联动活动，推动游戏用户活跃度显著攀升。中国大陆地区2025年上半年的平均DAU（日活跃用户数）超越2024年及2023年各年的平均DAU，特别是随着暑期更新及大型直播等市场推广，暑期（7月至本业绩公告日）平均DAU达到了2025年以来的峰值。《以闪亮之名》官方微博已累计获得约2,000万个转评赞，TapTap平台评分持续高达9.0分，截至2025年中期业绩公告发布之日，全球累计流水超过20亿元。《龙族：卡塞尔之门》是一款由虚幻引擎4打造的、根据《龙族》系列小说和动画改编及开发的策略卡牌类游戏。游戏在坚持数值和内容两条主线的基础上，强化内容线的迭代频率，利用赛季制玩法满足数值线玩家的新鲜感，并通过与旺旺、敦煌等联动活动提升游戏用户活跃度，结合暑期上线的全新主题活动及精心的运营规划，在中国大陆上线近一年后仍收获可观的新增用户量的同时维持了用户的长线黏性。伴随暑期上线的全新主题活动及精心的运营规划，游戏在中国大陆地区暑期的MAU（月活跃用户数）及平均DAU相较2025年上半年都实现了显著的增长，8月1日单日DAU与新增用户规模更创下了2025年以来的峰值。在中国大陆以外地区，随后游戏于2025年4月及8月分别在中国港澳台地区及东南亚地区上线，不仅取得了中国香港地区和中国台湾地区iOS游戏畅销榜第五名和第六名的良好成绩，且在泰国地区上线首日即冲入iOS游戏免费榜前三名，后连续多日位列iOS游戏免费榜前五名。此外，同样由虚幻引擎4打造的中国风修真题材放置RPG手游《踏风行》，于2025年5月16日在中国大陆地区正式上线。该游戏凭借卓越的美术表现，高度还原玩家对修真游戏的幻想，同时通过社交玩法，使不同类型的玩家得以获得良好的游戏体验，建立健康和谐的游戏生态。游戏预下载当日即登顶iOS游戏免费榜榜首。与此同时，对于《龙族幻想》、《梦幻诛仙》、《鸿图之下》等多款在运营中的经典游戏，公司持续进行运营投入，通过周年庆、版本更新等活动维护游戏健康的长线生态，各款游戏表现相对稳定并为集团持续贡献收益。特别值得关注的是，于2016年11月推出的回合制MMORPG手游《梦幻诛仙》，对比2024年同期及2024年下半年，2025年上半年的流水和新增用户量更是逆势实现了正向增长，体现了经典游戏的可玩性与长线生命力。多品类布局丰富产品矩阵 精品化战略注入发展新动力为打造多品类及风格多样的游戏组合，集团预期于2025年下半年至2027年期间在全球各地推出7款不同类型的游戏产品。游戏项目代号：逍遥是一款融合了国风和卡通美学的回合制MMORPG游戏，巧妙运用国风元素，将文化深度与艺术美感有机结合，希望让玩家在享受游戏乐趣的同时深刻感受中华传统文化的魅力。该游戏计划于2025年下半年对外开展测试。项目K是一款由虚拟引擎5制作的女性向游戏新作，目前正在全力推进中。此外，一款基于知名IP改编、以西方奇幻题材为背景的策略卡牌游戏项目G，预期将于2027年全球上线。日后，随着产品类型由MMORPG、女性向、策略卡牌、SLG扩张至放置RPG、数值卡牌等多品类和丰富多样的风格，及不断完善"研运一体"的有机模式，预期公司游戏的生命周期将进一步延长，这将对公司收益作出更稳定及持续的贡献。技术创新赋能游戏品质提升 研运一体及全球化战略提升竞争优势作为在业内率先研究和使用虚幻引擎开发移动游戏的游戏厂商，祖龙娱乐持续探索前沿科技，充分发挥团队在技术储备上的深厚积累，持续深入优化移动设备次世代效果，保持移动游戏领域的竞争优势和持续突破，并深入研究UE5的新技术高质量数字人（Metahuman）和智能城市交通系统（MassAI），根据在研产品探索和适配，将产品的渲染效果和场景角色体验提升到新的层级。与此同时，不断优化游戏在Steam和Epic平台的呈现，并结合玩家需求和产品特点继续拓展在PC端的适配与高品质呈现，逐步构建产品在多平台的游戏开发和推广的全球体系。展望未来，作为中国手游行业的开拓者，祖龙娱乐将持续深入研究虚拟引擎技术与AI在游戏开发中的应用，通过玩法的创新和品类的拓展提升游戏的产品力，不断开发多品类领先的精品游戏，同时，深化多元化产品赛道布局和IP生态建设，全力开拓丰富高质量产品赛道，持续积极推进精品化、多元化、全球化和研运一体的战略，基于优质的内容输出和日趋成熟的多元化产品矩阵，为全球玩家创造卓越的在线娱乐体验。关于祖龙娱乐有限公司祖龙娱乐是中国手游行业的开拓者，专注于开发优质MMORPG、女性向、策略卡牌、SLG及其他类型的手游，开发优质手游的实力屡经验证，且注重核心游戏性体验品类的持续深耕。截至2025年中期业绩公告发布之日，祖龙娱乐在逾170个地区市场共推出24款精品手游，支持14种语言的多个地区版本，所提供的高质量的多元游戏组合拥有良好的市场声誉。 Copyright 2025 亚太商讯 via SeaPRwire.com.

香港, 2025年8月22日 - (亚太商讯 via SeaPRwire.com) – 近年来，人工智能与高性能计算的快速发展，以及新能源汽车和智能驾驶产业加速渗透，推动着PCB（印制电路板）行业进入新一轮高景气周期。作为承载核心计算组件的关键载体，高端PCB正成为科技企业抢占未来制高点的战略支撑。在这一领域，胜宏科技（惠州）股份有限公司（「胜宏科技」）凭借领先技术、高质量产品和行业领先产能优势，已成长为全球高端PCB的领军者。根据弗若斯沙利文的资料，以2025年第一季度人工智能算力PCB收入规模计，胜宏科技市场份额位居全球第一。8月20日，胜宏科技向港交所递交上市申请，拟通过「A+H」两地资本市场布局，为下一阶段的跨越式发展蓄力。核心技术壁垒 铸就全球高端PCB领导者胜宏科技的核心竞争力，来自其在高端PCB领域构筑的深厚技术壁垒。公司以全链条创新体系为支撑，覆盖技术研发、工艺优化到量产应用的全流程环节，并围绕支撑AI算力的关键PCB技术路线，在工艺技术、制造技术和材料创新等方面提前进行技术储备和攻关，持续夯实竞争壁垒。胜宏科技作为PCB行业技术引领者，经过前瞻性技术布局，公司具备生产100层以上高多层PCB制造能力，70层以上高多层PCB量产能力，是全球首批实现6阶24层HDI产品大规模生产，以及8阶28层HDI与16层任意互联（Any-layer）HDI技术能力的企业，并能够支持PCIe6.0、1.6T 光模块等新一代前沿通信技术。公司应用于Eagle/Birch Stream/Turin平台服务器领域的产品均已实现批量化生产，下一代Oak Stream/Venice平台服务器也已进入测试阶段。在算力和 AI 服务器领域，胜宏科技是全球首批实现6阶24层HDI大规模量产的企业，并已启动10阶30层HDI研发认证，线宽/线距已突破至40/40μm；其100层以上产品技术研发储备亦远超行业平均水平。在材料创新方面，胜宏科技已完成M7及M8级材料在产品中的电性能和热性能验证，并推进M9级材料认证，支持224Gbps高速传输，为AI服务器及交换机的升级做好了充分准备。凭借领先的研发成果、规模化产能与国际化交付体系，胜宏科技成为众多全球顶尖科技企业的重要合作伙伴。在AI算力卡、AI Data Center UBB &交换机领域，胜宏科技市场份额全球领先，成为行业不可替代的供应商。卡位AI与智能驾驶黄金赛道 打开成长天花板凭借研发技术优势、制造技术优势和质量技术优势，胜宏科技实现大规模量产，推动业绩高速增长。2022年至2024年，公司收入从人民币78.85亿元增至107.31亿元，利润从7.91亿元增至11.54亿元，复合年增长率分别为16.7%及20.8%，进入2025年，胜宏科技延续强劲增长，一季度收入同比大增80.3%，利润同比飙升339.2%，盈利能力进一步跃升。从行业维度来看，人工智能与高性能计算、智能终端、汽车电子、网络通信等行业的不断升级，正驱动PCB市场正迎来结构性增长机遇，高端PCB需求快速攀升。在AI领域，技术迭代和应用落地引爆算力需求。根据弗若斯特沙利文的资料，预计到2029年全球人工智能及高性能计算PCB市场规模将增至150亿美元，2024-2029年复合年增长率达到20.1%。在汽车电子领域，新能源汽车与智能驾驶加速渗透，同样推升高性能PCB需求。预计到2029年，全球汽车电子PCB市场规模将增至111亿美元，其中，14层及以上高多层PCB市场规模预计达12.0亿美元，2024-2029年复合增长率达8.1%； 高阶HDI市场规模预计达9.0亿美元，2024-2029年年复合增长率达8.6%。作为深耕高端PCB的全球领导者，胜宏科技凭借技术领先2-3年的量产实力、全球第一的市场份额以及在AI算力与新能源汽车赛道的前瞻布局，已成为产业升级的核心受益者。随着行业规模的持续扩容，公司领先的市场份额有望进一步放大。此外，公司还在智慧终端机、5G通信及高端医疗等领域积极布局，拓展新的成长空间。伴随着多元应用场景进入升级周期，胜宏科技的成长动能与业绩释放潜力将持续增强。此次递表港交所，藉助香港这一国际金融中心的资本与流动性优势，胜宏科技有望进一步拓宽融资管道，提升全球资本市场的认可度和透明度；另一方面，H股平台将帮助公司加快海外产能布局，提升与国际客户的战略协同，进一步夯实其全球化竞争优势。随着AI与新能源产业的持续爆发，胜宏科技有望在「技术创新+资本赋能」的双轮驱动下，进一步夯实全球领导地位，并持续释放长期成长价值。 Copyright 2025 亚太商讯 via SeaPRwire.com.

2025 Interim Results Highlights- Total revenue increased by 9.40% YoY to approximately NTD585.31 million- Gross profit increased by 28.98% YoY to approximately NTD201.97 million- Overall gross profit margin rose by 5.24 percentage points to approximately 34.51%- Total comprehensive income attributable to owners of the Company for the period increased significantly by118.02% YoY to approximately NTD68.24 million- Revenue from turnkey solutions reached approximately NTD113.69 million- Basic earnings per share increased by 25.84% YoY to approximately NTD4.87 centsHONG KONG, Aug 21, 2025 - (ACN Newswire via SeaPRwire.com) - Genes Tech Group Holdings Co. Ltd (“Genes Tech Group” or “The Group”, Stock Code: 8257.HK) announces its interim results for the six months ended 30 June, 2025 (“During the period”). During the period, the Group’s performance demonstrated steady growth. The total revenue of the Group reached approximately NTD585.31 million, representing a year-on- year (“YoY”) increase of 9.40%. Total comprehensive income attributable to owners of the Company for the period amounted to approximately NTD68.24 million, representing a significant YoY increase of 118.02%. Basic earnings per share were approximately NTD4.87 cents, representing a YoY increase of 25.84%.During the period, revenue from turnkey solutions amounted to approximately NTD113.69 million, accounting for approximately 19.42% of the Group’s total revenue. The revenue from trading of parts and used SME amounted to approximately NTD471.62 million, accounting for approximately 80.58% of the Group’s total revenue. The Group adheres to its core strategy of prudence and stability, striving to strengthen the stability and continuity of cooperation with existing international clients while actively expanding new clientele to diversify risks. During the period, the Group’s revenue from operations in the United States increased significantly by 78.54% from last year, accounting for approximately 38.68% of the total revenue of the Group, while revenue from operations in Taiwan increased by 48.97% from last year, accounting for approximately 49.69% of the total revenue the Group.In the first half of 2025, the global semiconductor market continued its growth momentum. Driven by new technologies such as AI, the penetration rates of new technologies and products in areas such as automotive electronics, new energy, the Internet of Things, big data and artificial intelligence continued to rise. Furthermore, the deepening development of cutting-edge technologies such as “AI+” and “5G+”, along with the rapid growth in demand for AI computing power, have become key drivers of semiconductor demand, creating a favorable development environment for semiconductor companies. According to the latest report from the Semiconductor Industry Association (SIA), global semiconductor sales reached USD59 billion in May 2025, up 19.8% from USD49.2 billion in May 2024, marking 19 consecutive months of year-on-year growth and a 3.5% increase from the previous month. The growth in the global chip market was primarily driven by strong demand from the Americas and Asia- Pacific regions.Mr. Yang Ming-Hsiang, Chairman and Chief Executive Officer concluded: “Driven by the strong momentum of AI technology, the semiconductor industry is entering a period of rapid growth in economic profits. However, amidst the current volatile international landscape, the semiconductor industry faces challenges in supply chain stability. The Group will assess the situation, pursue progress while maintaining stability, and continuously enhance its core value and competitiveness to create sustainable long-term investment returns for shareholders.”About Genes Tech Group Holdings Co. Ltd (Stock Code: 8257.HK)Genes Tech Group Holdings Co. Ltd is a turnkey solution provider and exporter of parts and used SME in Taiwan. Since the commencement of its business in 2009, the Group mainly engaged in providing turnkey solution for parts and used SME for its customers and modifying and/or upgrading the semiconductor equipment of its production systems according to customers needs. In addition, the Group is also engaged in the trading of SEM and parts. The SME and parts supplied by the Group included furnaces, clean tracks and other related items, which were used at the front-end of the semiconductor manufacturing process, wafer fabrication such as deposition, photoresist coating and development, and these were extensively applied in mobile phones, game consoles, DVD players, automotive sensors and other digital electronic products.The press release is distributed by Vitalink Consultants Limited on behalf of Genes Tech Group Holdings Co. Ltd. For enquiry, please contact:Ms. Natural Lau Tel: (852) 2529 7999 Email: Natural.lau@vitalink.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 21, 2025 - (ACN Newswire via SeaPRwire.com) - Ta Yang Group Holdings Limited (“Ta Yang Group” or the “Group”; Stock Code: 1991), a well-established Hong Kong-listed company with nearly two decades of market presence, plans to further advance comprehensively into the Web 4.0 field and artificial intelligence (AI) industry. The Group will leverage AI Digital Humans as its subsequent growth engine, integrating a Real World Assets (RWA) tokenization operation platform with its inherent global traffic marketing operation system to strategically deploy across three trillion-dollar sectors: education, gaming, and big health.Against the backdrop of AI fueling a new wave of global digitization, AI is evolving from a “technological tool” to the “core of transformation” for many enterprises, driving industries to change work methods, overcome efficiency boundaries, and reshape value paradigms. IDC research indicates that for every dollar invested in generative AI, enterprises can achieve a return on investment of 3.7 times; companies deeply embracing AI have realized an average value return cycle of 13 months. Over 50% of organizations are accelerating customized AI application development, converting short-term gains into long-term competitive advantages. PwC forecasts that by 2030, AI will be a global economic game-changer, contributing up to US$15.7 trillion in growth and adding approximately 26.1% to China’s GDP. It is no surprise that AI Digital Humans, as the core multi-modal interactive carriers across industries, are gradually transitioning from concept to industrial implementation.In 2023, the Group invested in Jusheng Technology Co., Ltd. (“Jusheng Technology”), a professional digital marketing services company. Jusheng Technology plans to launch its independently developed AI Digital Humans, integrating leading technologies such as machine learning, natural language processing (NLP), computer vision (CV), speech synthesis/recognition (TTS/STT), and compatible with the xAI Grok API. This AI Digital Human is at an industry-leading level and will be introduced to three major scenarios: education, gaming, and big health. This includes, but is not limited to: a “Virtual Teacher” AI Digital Human that can adjust speaking speed and learning difficulty in real time based on students’ attention; AI NPCs in games with personalized storylines that evolve based on different player choices; and a “Health Companion” AI Digital Human offering proactive suggestions based on individuals’ 24/7 health data such as heart rate and blood pressure. The Group plans a “phased iterative and gradual open” strategy, expecting to complete the core modules and underlying technology integration within six months, release AI Digital Human prototypes for the three scenarios in the following 6 to 18 months, and integrate these into Jusheng Technology’s marketing matrix. Between 18 and 36 months, the Group aims to open related APIs or SDKs and attract global developers to build an open ecosystem.Additionally, the Group intends to take advantage of this AI and digital transformation opportunity by using blockchain-based RWA to enable off-chain cash flow-generating asset projects to be captured in real time by AI Digital Humans and recorded in smart contracts. The Group will structure and issue layered packages of assets including educational copyrights and gaming IPs tailored to investors’ risk preferences. The target for this type of asset issuance is to pilot 10 high-quality projects in the first year, with plans to expand to 100 projects within three years, involving total asset values of HK$500 million. The Group aims to serve total asset values exceeding HK$5 billion within five years, establishing a multi-domain RWA asset operation platform.It is noteworthy that RWA transactions eliminate the need for traditional brokers or intermediaries, enabling a direct connection between the physical economy and virtual markets. According to Boston Consulting Group estimates, the RWA tokenization market could grow to a valuation of US$16 trillion by 2030, underscoring its vast market potential and promising outlook.Leveraging Jusheng Technology’s 20 years of cross-border marketing experience, Ta Yang will build a traffic system characterized by “comprehensive coverage + intelligent operation + scalable growth.” Jusheng Technology’s platforms cover overseas social media such as TikTok, Instagram, Facebook, as well as domestic channels like Douyin and WeChat Video Accounts, facilitating global user reach for customers. Utilizing AI technology, processes such as account nurturing, content generation, and targeted delivery will be fully automated to reduce operational costs and improve customer acquisition efficiency. Based on this, Ta Yang Group has a clear user growth target: to attract 1 million users in the first year to form an initial traffic pool, reach over 10 million users within three years, and build a native Web 4.0 traffic pool of hundreds of millions of users within five years, creating a “traffic – conversion – repurchase” cycle.Ms. Shi Qi, Chairlady of Ta Yang Group, stated, “Ta Yang is unveiling its AI transformation blueprint and formally entering the digital asset arena, marking a significant milestone for the Group and opening a new chapter for future development. We are grateful for investors’ recognition and confidence in our growth. As a well-established Hong Kong-listed company with nearly two decades of market history, this entry into the AI industry is expected to generate four types of revenue: income from AI Digital Human-driven traffic; revenue from providing AI+RWA one-stop financing consultancy services to SMEs; matchmaking fees related to RWA transactions, as well as digital advisory subscription fees; and multilingual, multicultural AI customer service and marketing outsourcing fees charged on a per-project or annual basis. Benefiting from its business model, Jusheng Technology has maintained positive cash flow in recent years, providing ample resources for this broader AI and digital transformation initiative. As the Group’s vision through Jusheng Technology in AI gradually materializes, we look forward to creating greater value and delivering promising returns for our shareholders.”About Ta Yang Group Holdings Limited (SEHK: 1991.HK)Ta Yang Group Holdings Limited (Stock Code: 1991) was established in 1991 and successfully listed on The Stock Exchange of Hong Kong Limited in 2007. It is a diversified enterprise combining three decades of industry experience with a forward-looking digital vision. Since its founding, the Group initially focused on the field of silicone input devices, specializing in the design and manufacture of core components used in consumer electronic devices, computers, laptops, mobile phones, and automotive peripherals. Leveraging a highly integrated production system, stringent quality control, and technological innovation capabilities, the Group has earned long-term trust from numerous globally renowned brand clients, laying a solid industrial foundation.With the deepening wave of global digital transformation, Ta Yang Group has keenly identified strategic opportunities in the digital economy era and decisively launched a comprehensive strategic transformation toward the Web 4.0 domain. Centered on “embracing technological change and reshaping the value ecosystem,” the Group precisely anchors on three core drivers: artificial intelligence (AI), Real World Assets (RWA) tokenization, and Hong Kong’s policy ecosystem. It is dedicated to bridging the transformation chain of “data — assets — value,” marking its leap from a traditional manufacturing enterprise to a digital economy pioneer.Currently, Ta Yang Group regards its Web 4.0 strategic transformation as a new starting point, focusing on the three trillion-dollar sectors of education, gaming, and big health. It aims to become a leading enterprise in the Asia-Pacific region across the dual arenas of AI and RWA, providing efficient value growth ecosystems for global investors, partners, and individual users. The Group is committed to continuously advancing high-quality development of the global digital economy and writing a new chapter from being an “industry deep cultivator” to a “digital ecosystem builder.” Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 22, 2025 - (ACN Newswire via SeaPRwire.com) - Everbright Grand China Assets Limited ("Everbright Grand China" or the "Group"; HKEX stock code: 03699.HK), a subsidiary of China Everbright Group, principally engaged in the businesses of property leasing, property management and the sales of properties held for sale, announced its interim results for the six months ended 30 June 2025 ("Reporting Period").During the Reporting Period, revenue of the Group was approximately RMB24.5 million, representing an increase of approximately RMB0.6 million as compared with 2024. Profit attributable to equity shareholders was approximately RMB10.1 million, representing a decrease of approximately RMB1.3 million as compared with 2024, mainly attributable to the increase in the PRC income tax and deferred taxation. Gross profit was approximately RMB18.1 million, representing an increase of approximately RMB0.6 million as compared with 2024. Basic earnings per share of the Group was approximately RMB2.30 cents (2024: RMB2.59 cents). The Board declared an interim dividend of RMB0.73 cents (equivalent to HK0.80 cents) per ordinary share.Considering that the current operating environment remains relatively challenging, the Board declared an interim dividend of RMB0.73 cents (equivalent to HK0.80 cents) per ordinary share, as a token of appreciation to shareholders for their continuous support. In the second half of the year, the Company will decide on dividend distribution taking into account factors such as business development needs, financial performance and capital position, as well as performance growth, in order to bring the best return to the Company's shareholders and investors.In 2025, global economic environment continues to be characterized by uncertainties. Factors such as geopolitical risks, inflationary pressures and monetary policy adjustments in major economies around the world continue to affect market confidence and capital flows. Nevertheless, the overall stability of China’s economy, the gradual rebound of the consumer market and the continued optimization and upgrading of the industrial structure have provided a solid foundation for the development of the property management and leasing industry.For the six months ended 30 June 2025, the Group generated rental income of approximately RMB17.0 million (2024: RMB16.3 million), representing an increase of approximately RMB0.7 million as compared to the same period last year. The Company’s properties maintained an occupancy rate of approximately 81%, with the overall leasing market performing solidly, although newly signed rents declined compared to the previous period. In the face of downward pressure on rents, the Group will enhance its consolidated earning power by adding additional services to new leases to mitigate the impact of lower rents on overall revenue. This not only enriches the service offerings, but also helps to enhance customer stickiness and satisfaction, further consolidating the Group’s market competitiveness.During the period, revenue from the property management services was approximately RMB7.5 million (2024: RMB7.6 million), representing a decrease of approximately RMB0.1 million as compared to the same period last year. In terms of property portfolio strategy, the Group actively promotes tenant diversification to mitigate industry risks and adapt to the accelerated rise and fall of market environment of various industries. The Group’s existing properties are mainly concentrated in two core cities of Chengdu in Sichuan Province and Kunming in Yunnan Province, covering three commercial buildings, namely Everbright Financial Center, Everbright International Mansion and Ming Chang Building, with a total gross floor area of approximately 89,507 square meters. Benefiting from its excellent geographical location and sound property quality, it has attracted a large number of state-owned enterprises and large organizations to move in and has a solid leasing base. In the future, the Group will promote business diversification to enhance its overall risk-resistant capability.In terms of overseas investment, the Group is evaluating investment opportunities in international markets and is cautiously optimistic about overseas markets. Notwithstanding the volatility of the global economy, the Group will adhere to the principle of prudence and flexibility in its investment horizon to ensure the safety and profitability of its capital operations.As at 30 June 2025, The Group maintained cash and bank balances and bank deposits of approximately RMB236.2 million (31 December 2024: RMB231.5 million). The Group’s gearing ratio, being measured by the Group’s total liabilities over its total assets, was 18.6% (31 December 2024: 18.0%). The Group’s liquidity position was well-managed.Looking ahead to the second half of 2025, there are no new property management projects for the time being, despite favourable lease performance in the first half of the year. The Group is actively looking for suitable investment windows for its acquisition and investment plans which were delayed during the epidemic. With the active domestic economy and falling interest rates, the market’s willingness to invest has increased significantly.The Group will continue to deepen its digital transformation and actively utilize technology to promote the construction of intelligent properties and enhance operational efficiency and customer experience. Through technological empowerment, we optimize the allocation of human resources and service processes, enhance the level of intelligence and refinement of property management, and improve overall service quality and customer satisfaction.In addition, the Group will fully utilize the synergies with its parent company, China Everbright Group, and leverage on the popularity of the “Everbright” brand and its resource advantages to actively develop diversified value-added services, enrich its revenue structure and enhance its brand influence. In the face of industry restructuring and upgrading, the Group insists on stable operation, focuses on risk management and internal control, responds flexibly to changes in the macro-economy and policies, and continues to optimize its asset portfolio in order to enhance its risk-resistant capability. Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年8月22日 - (亚太商讯 via SeaPRwire.com) - 光大永年有限公司，为中国光大集团旗下物业租赁、及物业管理及销售持作出售物业公司（「光大永年」或「集团」，香港联交所股份代号：03699.HK）今天公布截至2025年6月30日止（「报告期内」）之中期业绩。报告期内，集团的收益约为人民币24.5百万元（2024年：人民币23.9百万元），较去年同期增加约人民币0.6百万元，主要由于租赁收入增加所致。本公司权益股东应占溢利约为人民币10.1百万元（2024年：人民币11.4百万元），较去年同期减少约人民币1.3百万元，乃主要由于中国所得税及递延税项增加所致。集团录得毛利约人民币18.1百万元（2024年：人民币17.5百万元），较去年同期增加约人民币0.6百万元。每股基本盈利约为人民币2.30分（2024年：人民币2.59分）。考虑到目前经营环境仍是面对比较大挑战的情况下，董事会宣布派发截至2025年6月30日止六个月之本公司中期股息每股普通股人民币0.73分（相当于0.80港仙）（2024年：人民币0.78分（相当于0.85港仙）），以答谢股东一直以来的支持。2025年，全球经济环境依然充满不确定性，地缘政治风险、通胀压力及全球主要经济体货币政策调整等因素持续影响市场信心和资本流动。尽管如此，中国经济保持总体稳定，消费市场逐步回暖，产业结构持续优化升级，为物业管理及租赁行业提供了稳健的发展基础。截至2025年6月底，本集团的租金收入约为人民币17.0百万元（2024年： 人民币16.3百万元），较去年同期增加约人民币0.7百万元，旗下物业出租率维持在约81%（2024年：77%），整体租赁市场表现稳健，但新签订租金水平较此前有所下降。面对租金下调压力，本集团将通过在新租约中增加附加服务，提升综合收益能力，缓解租金下降对整体收入的影响。此举不仅丰富了服务内容，也有助于增强客户粘性和满意度，进一步巩固本集团的市场竞争力。物业管理服务的收益约为人民币7.5百万元（2024年：人民币7.6百万元），较去年同期下降约人民币0.1百万元。在物业组合策略方面，本集团积极推动租户多元化，分散行业风险，适应各行业兴衰加速的市场环境。本集团现有物业主要集中于四川成都和云南昆明两大核心城市，涵盖光大金融中心、光大国际大厦及明昌大厦三栋商业楼宇，总建筑面积约89,507平方米。得益于优越的地理位置和良好的物业质量，吸引了大量国有企业及大型机构入驻，租赁基础稳固。未来，本集团将推动业务多元化发展，提升整体抗风险能力。海外投资方面，本集团正评估国际市场的投资机会，体现出对海外市场的审慎乐观态度。尽管当前全球经济波动较大，本集团将坚持稳健原则，灵活把握投资窗口，确保资本运作的安全性和收益性。于2025年6月30日，本集团持有现金及银行结余以及银行存款约为人民币236.2百万元（2024年12月31日：人民币231.5百万元）。资本负债比率（按本集团总负债除以总资产计量）为18.6%（2024年12月31日：18.0%）。本集团的流动资金状况良好。展望2025年下半年，尽管上半年租约表现良好，但暂无新增物业管理项目。疫情期间延迟的收购及投资计划，随着国内经济活跃和利率下调，市场投资意愿明显增强，本集团正积极寻找合适的投资窗口。本集团将继续深化数字化转型，积极运用科技，推动智慧物业建设，提升运营效率和客户体验。通过技术赋能，优化人力资源分配和服务流程，增强物业管理的智慧化和精细化水平，提升整体服务质量和客户满意度。此外，本集团将充分发挥与母公司中国光大集团的协同效应，借助"光大"品牌的知名度和资源优势，积极拓展多元化增值服务，丰富收入结构，提升品牌影响力。面对行业转型升级，本集团坚持稳健经营，注重风险管理和内部控制，灵活应对宏观经济及政策变化，持续优化资产组合，增强抗风险能力。 Copyright 2025 亚太商讯 via SeaPRwire.com.

香港，2025年8月22日 - (亚太商讯 via SeaPRwire.com) - 中联发展控股集团有限公司（下称「本公司」；联交所编号：0264）欣然宣布，已签订最终协议收购香港金融科技创新企业 - NVTHK有限公司（「NVT」）20%股权。NVT为现实资产（「RWA」）代币化市场的先行者。通过本次战略性收购，公司已站在一个有望重塑全球资本市场，并于未来数年实现高速增长的行业前沿。NVT - 开创性市场先行者NVT是香港领先的RWA代币化基础设施提供商，通过其强大的OTC平台，构建了行业首个可支持顶级金融机构一级发行和受监管代币化资产链上二级交易的完整生态系统。其高度整合的封闭式平台，连接资产发行人、投资者及流动性提供者，为金融业带来前所未有的效率及流动性。NVT拥有享誉盛名的机构级客户阵容，涵盖顶尖金融机构、资产管理人及Web3创新企业，包括信达国际资管、广发证券、金洲资产管理、Animoca Brands及HashKey Group。现时平台支援多类型金融产品的代币化发行，如货币市场基金、结构性产品、债券及私募股权基金，展现其广泛应用及市场认可度。此次收购对中联发展控股的战略意义根据波士顿咨询集团（BCG）于2025年4月发布的报告，全球RWA代币化市场预计将由2025年的0.6万亿美元在中位情景下增长至2033年的18.9万亿美元，年均复合增长率达53%。该行业的快速扩张反映了机构及零售投资者对高收益、透明且易于直接投资的资产类别的需求日益增加。透过收购NVT 20%股权，本公司将获得：- 经验丰富且全面合规的一站式机构级代币化平台；- 独家接入香港首个可在链上OTC市场进行二级交易的RWA生态系统；- 已建立的全球分销网络 - 迅速连接流动性提供者、资产发行人及投资者；- 与行业领袖伙伴携手进一步建立市场公信力及拓展市场触及范围。本次收购大幅加速公司进军高速增长的RWA市场，无需承担从零自建平台所带来的延误、风险与资本开支。该收购亦符合本公司致力于探索创新与新业务机会，以实现收入多元化的承诺。战略合作领域在此次投资完成后，公司与NVT将于两大战略范畴展开合作：皮革生产及供应链RWA代币化依托NVT平台，本公司将率先于全球推动皮革行业实体及无形资产（包括现金流、应收帐款、存货及知识产权等）的代币化，实现营运资金释放、开拓新投资渠道、自动化结算并拓展全球流动性。拓展新的RWA垂直领域双方将共同开发并规模化推进其他行业的RWA解决方案，结合本公司产业专长与NVT经验验证的基础设施，把握多元资产类别中的潜在机遇。中联发展控股集团有限公司行政总裁赵靖飞表示："本次投资NVT代表着公司跨越性发展的重要一步。NVT作为行业先行者及领导者，结合独有链上一级及二级交易能力及卓越客户基础，令我们可深度参与万亿级增长机遇，加速核心业务数码化并创造长远股东价值。"NVT创办人兼行政总裁赵建公表示："我们的使命是运用区块链技术重新定义资本市场，特别聚焦于亚洲金融中心 — 香港。通过与中联发展的合作，我们将来自实体产业的优质资产引入并无缝对接至资本市场。此次合作不仅进一步强化了我们的平台实力，也为我们的合作伙伴生态系统创造了可观的价值增长机遇，同时明确聚焦于为股东实现长期回报最大化。我们所构建的仅仅是一个开始 — 在未来，全新的商业模式、创新的资产类别以及可扩展的增长潜力将展现出无限可能。"关于NVTNVTHK有限公司（「NVT」）为总部位于香港的金融科技创新企业，专注现实资产（RWA）代币化基础设施、虚拟资产经纪系统及稳定币技术方案。NVT 为香港首家通过 OTC 平台实现受监管代币化资产链上交易的企业，为发行人、投资者及中介机构提供企业级技术解决方案。关于中联发展控股集团有限公司中联发展控股集团有限公司（「CIDC」）于开曼群岛注册成立，并于香港联合交易所主板上市（股份代号：0264）。作为一家成熟的投资控股公司，CIDC 在高品质皮革制品的制造与分销方面建立了坚实基础。CIDC 积极推动创新与转型战略，寻求突破传统核心业务的更多机遇。公司始终致力于寻找新业务与价值创造的契机，并适时扩展经营范畴与投资版图。传媒垂询：NVTHK有限公司梁海燕 电话:2522 3869 电邮: Olivia.leung@newvisiongp.com 网址: www.nvt.cim.hk Copyright 2025 亚太商讯 via SeaPRwire.com.

2025年中期业绩亮点- 业务总收益同比增长9.40%至约新台币585.31百万元- 毛利同比增长28.98%至约新台币201.97百万元- 整体毛利率则上升5.24个百分点至约34.51%- 本公司拥有人应占期间全面收益总额同比大幅增长118.02%约至新台币68.24百万元- 统包解决方案的收益约新台币113.69百万元- 每股基本盈利同比增长25.84%至约为新台币4.87仙香港，2025年8月21日 - (亚太商讯 via SeaPRwire.com) - 靖洋集团控股有限公司（「 靖洋集团」或「集团」，股份代号：8257.HK）宣布截至 2025年6月 30 日止六个月（「期内」）之中期业绩。期内，集团业绩呈现稳健增长态势。集团总收益达约新台币585.31百万元，同比增长9.40%。毛利同比增长28.98%，达约新台币201.97百万元，而整体毛利率则上升5.24个百分点至约34.51%。本公司拥有人应占期间全面收益总额约新台币68.24百万元，同比大幅增长118.02%。每股基本盈利约为新台币4.87 仙，同比增长25.84%。期内，统包解决方案的收益约新台币113.69百万元，占集团总收益约19.42%。零件及二手半导体制造设备买卖的收益约新台币471.62百万元，零件及买卖二手半导体制造设备占集团总收益约80.58%。本集团秉持着审慎、稳健的核心策略，致力强化与现有国际客户合作的稳定性和持续性，同时积极拓展新客户以分散风险。期内，本集团源自美国业务的收入较去年大幅增加78.54%，占集团总收益约38.68%，而源自台湾业务的收入则较去年增加48.97%，占集团总收益约49.69%。2025 年上半年，全球半导体市场延续增长态势。在AI 等新技术的驱动下，汽车电子、新能源、物联网、大数据和人工智能等领域的新技术、新产品渗透率持续提升。此外，「人工智能+」、「5G+」等前沿技术的深化发展，以及AI 算力需求的快速增长，均成为推动半导体需求的重要动力，为半导体企业营造了良好的发展环境。根据半导体产业协会最新报告，2025年5月全球半导体销售额达590亿美元，较2024年5月的492亿美元增长19.8%，连续19个月实现同比增长；环比则增长3.5%。全球芯片市场的增长主要受美洲和亚太地区强劲需求推动。靖洋集团主席兼行政总裁杨名翔先生总结：「在AI 技术的强劲驱动下，半导体行业迎来经济利润快速增长期。然而，当前国际形势波动，其亦面临供应链稳定性的挑战。本集团将审时度势，稳中求进，持续提升核心价值与竞争力，为股东创造可持续的长期投资回报。」关于靖洋集团控股有限公司（股份代号：8257.HK）靖洋集团控股有限公司为一间总部位于台湾的零件及二手半导体制造设备的统包解决方案供货商及出口商。集团自于2009年开始业务以来，主要为客户提供零件二手半导体制造设备件的统包解决方案，按客户需要改造及/或升级其生产系统的半导体设备，亦从事半导体制造设备及其零件买卖。集团所提供的半导体制造设备及零件包括热炉管、显影装置等，用于半导体的前端制造过程、晶圆加工，如沉积、光阻涂布及显影，更可广泛应用于手机、游戏机、DVD播放器，以及车用传感器等数码电子产品。本新闻稿由汇滔顾问有限公司代表靖洋集团控股有限公司发布。详情垂询：刘育然小姐电话：(852) 2529 7999电邮：Natural.lau@vitalink.com.hk Copyright 2025 亚太商讯 via SeaPRwire.com.

香港，2025年8月21日 - (亚太商讯 via SeaPRwire.com) - 大洋集团控股有限公司 (「大洋集团」或「集团」；股份代号：1991) 作为在港上市近廿载的老牌港股，拟进一步向Web4.0领域及人工智能（AI）产业全面进军，将以AI数字人作为其后续成长引擎，结合真实世界资产（Real World Assets，RWA）代币化运营平台，及其固有的全球流量营销运营体系，针对教育、游戏、大健康三大万亿赛道进行战略布局。在人工智能（AI）为全球数字化卷起新浪潮的大局下，AI正从「技术工具」跃升成为不少企业的「变革核心」，并驱使各行业改变工作方式、突破效率边界、重塑其价值逻辑。IDC研究显示，企业每投资1元在生成式AI身上，其投资回报率可达3.7倍；而深度拥抱AI的企业已实现平均13个月的价值回报周期，超过50%的组织正加速定制化AI应用开发，将短期收益转化为长期竞争优势。普华永道预测，到2030年，AI将成为全球经济的规则改变者，贡献高达 15.7 万亿美元的增长，为中国经济带来约26.1%的 GDP增量。无怪AI数字人作为不同行业多模式交互核心载体，已逐步从概念迈向产业落地。大洋集团于2023年投资的专业数位营销服务公司巨省科技有限公司（「巨省科技」）拟推出其自主研发、技术融合机器学习、自然语言处理（NLP）、计算机视觉（CV）、语音合成／识别（TTS／STT）等领先技术、可兼容xAI Grok API的AI数字人，此AI数字人处于行业领先水平，幷拟面向教育、游戏及大健康的三大场景推出，形成包括但不限于，如能够根据学生专注力实时调整语速及学习难度的「虚拟老师」AI数字人、藉因应每位玩家不同选择互动而衍生「玩家专属」的剧情之AI NPC、可根据个人7x24小时的健康数据如心率、血压等主动建议的「健康伴侣」AI数字人等；集团计划采取「分阶段迭代、逐步开放」的策略，即预期将于未来6个月内完成核心模块及底层技术整合，并目标于紧接的第6至18个月就上述三大场景发布AI数字人原型，幷接入巨省科技之营销矩阵，期望于第18至36个月内能开放相关API或SDK接口，并吸引全球开发者构建其开放式生态圈。除此之外，集团更拟透过是次向AI与数字化转型的契机，计划透过区块链RWA（Real World Assets，真实世界资产），将具备现金流的链下资产项目通过AI数字人实时抓取写进智能合约当中，并将针对教育版权、游戏IP在内等资产进行分层打包及发行，以配合不同投资者的风险偏好，集团目标此类资产发行，首年将对10个优质项目进行「试水式」发行，冀能于未来3年扩展至100个项目，涉及资产规模总值5亿港元；力争5年内服务的资产规模总值能突破50亿港元，打造出多领域RWA资产运营平台。值得留意的是，RWA交易过程中，无需传统经纪商或中间机构的参与，便可实现实体经济与虚拟市场的结合。根据波士顿咨询顾问公司的估计 =，至2030年，RWA代币化市场的市值规模可能成长至16万亿美元。由此可见，其巨大的市场潜力以至前景。依托巨省科技20年跨境投放经验，大洋集团将构建「全域覆盖+智能运营+规模增长」流量体系。巨省科技服务之平台覆盖TikTok、Instagram、Facebook等海外社交平台及抖音、微信视频号等国内渠道，有助客户实现全球用户触达；并可借助AI技术实现账号养号、内容生成、定向投放全流程自动化，降低运营成本，提升获客效率。以此推算，大洋集团对用户增长目标明确：首年引流100万用户构建初始流量池，目标3年内超千万，5年内打造亿级Web4.0原生流量池，形成「流量－转化－复购」的循环。大洋集团将藉上述规划打造「数据化（Digitalization）－资产化（Assetization）－代币化（Tokenization）（下称‧DAT）」闭环，实现价值三层转化：于数据化阶段，将教育教案、游戏脚本等多元数据标准化，打破数据孤岛；在资产化阶段，将用户交互沉淀换算为可量化资产，比如教育「个性化教研数据包」可提升AI数字人老师课程之续费率、游戏「剧情扩展资产」延长游戏生命周期等；在代币化阶段，将可通过滴灌通DRO模型质检之达标资产上链发行，全球投资者可7×24小时交易，放大流动性溢价。针对上述AI及数字化转型战略蓝图的投入规划，大洋集团预期首年投入1.3亿港元，目标未来5年内实现现金流正向循环。大洋集团主席施琦女士表示：「大洋发布助力企业AI与数字化转型蓝图，并正式进入数字资产领域，标志着集团一项重要里程碑，亦为未来更多元化发展掀开崭新的一页。我们感谢各投资者对公司以发展的肯定及信心。大洋集团作为一间在港上市近廿载的老牌港股，透过是次涉足AI产业的举措，未来有望衍生四种收入，包括AI数字人引流的收入、为中小企业提供 AI+RWA 一站式融资咨询的收入、与RWA交易相关的撮合手续费以至数字投顾订阅费、以及按项目或年费提供多语言、多文化 AI 客服与营销外包收入，且巨省科技受惠其业态，近年持续保持正向现金流，亦为是次其向AI及数字转型进一步拓展大计，提供充裕的自有资源，而随着集团透过巨省科技走入AI领域的蓝图逐步变成现实，届时可望为股东创造更多价值幷带来理想回报。」关于大洋集团控股有限公司(股份代号: 1991)大洋集团控股有限公司（股票代号：1991）成立于 1991 年，2007 年在香港联合交易所有限公司成功上市，是一家兼具三十年产业积淀与前瞻数字视野的多元化企业。自创立以来，集团早期聚焦硅胶输入设备领域，专业设计及制造用于消费电子装置、计算机、笔记本电脑、手提电话及汽车周边产品的核心部件，凭借高度整合的生产体系、严苛的品质管控与技术创新能力，赢得全球众多知名品牌客户的长期信赖，奠定了坚实的产业根基。随着全球数字化转型浪潮的深化，大洋集团敏锐洞察数字经济时代的战略机遇，果断启动向 Web4.0 领域的全方位战略转型，以「拥抱技术变革、重构价值生态」为核心方向，精准锚定人工智能（AI）、真实世界资产（RWA）代币化及香港政策生态三大核心驱动力，致力于打通 「数据 — 资产 — 价值」 的转化链路，开启从传统制造向数字经济领航者的跨越。当前，大洋集团正以 Web4.0 战略转型为新起点，聚焦教育、游戏、大健康三大万亿赛道，致力于成为亚太地区 AI 与 RWA 双赛道的领先企业，为全球投资者、合作伙伴及个人用户提供高效的价值增长生态，持续推动全球数字经济高质量发展，写下从「产业深耕者」到「数字生态构建者」的全新一页。如有任何问题，欢迎垂询达博思传讯顾问有限公司陈铠瑶(Joanne Chan)电话：(852) 9616 2676 电邮：jchan@lbs-comm.com何幸儒 (Jason Ho) 电话：(852) 9836 3448 电邮：jho@lbs-comm.com Copyright 2025 亚太商讯 via SeaPRwire.com.

HONG KONG, Aug 21, 2025 - (ACN Newswire via SeaPRwire.com) - Focusing on the field of tumor treatment, innovative biopharmaceutical company Lepu Biopharma Co., Ltd. (Lepu Biopharma or the Company, stock code: 2157.HK) announced its interim results for the first half of 2025. During the reporting period, the Company's business showed strong growth momentum, achieving profitability for the first time. Core product sales and international licensing business progressed in tandem, with multiple ADC pipeline products entering key clinical stages and global commercialization efforts accelerating.Lepu Biopharma is an innovation-driven biopharmaceutical company focusing on oncology therapeutics, in particular, targeted therapy and oncology immunotherapy, with a strong China foundation and global vision. Lepu Biopharma is dedicated to developing innovative ADCs through our comprehensive and advanced ADC technology development platform and we aim to develop optimal and innovative drugs to better serve the unmet medical needs of cancer patients. The Company is committed to continuously developing a market-differentiating pipeline by fully integrating independent innovation capabilities and strategic collaborations. The Company has established and is progressively expanding our internal manufacturing capabilities, driven by the business needs stemming from the upcoming commercialization of our ADC candidates.Currently, Lepu Biopharma has strategically designed our pipeline with a range of oncology products. For clinical-stage candidates, the Company has one clinical/commercialization-stage drug candidate; nine clinical-stage drug candidates, including one co-developed through a joint venture; and three clinical-stage combination therapies of our candidates. One of our drug candidates has obtained marketing approval with respect to two of its targeted indications, with clinical trials for other indications ongoing. Among the nine clinical-stage drug candidates, seven are targeted therapeutics and two are immunotherapeutics, which are an oncolytic virus drug and T cell agonistic antibody.As of the end of the reporting period, Lepu Biopharma has achieved significant milestones in the monetisation of our R&D capabilities through commercialization and BD activities: PUYOUHENG (Pucotenlimab Injection) has completed the full commercialization process and is currently under a rapid sales growth, and four other products, CMG901, MRG007 and two pre-clinical TCE assets have also been licensed out through our BD activities. Notably, CMG901’s global rights have been licensed to AstraZeneca, and MRG007’s rights for regions outside Greater China have been licensed to ArriVent. Two pre-clinical TCE assets have entered into a collaboration with Excalipoint.Revenue scale achieved a 3.5-fold leapfrog growth, with comprehensive improvement in financial indicatorsIn the first half of 2025, the Company made significant progress in advancing its product pipeline and business operations, recording a total revenue of approximately RMB466 million, which was an increase of 350% of the same period in 2024 at RMB133 million. For licensing activities, the Company has recognized approximately RMB309 million in revenue primarily from the out-licensing of MRG007. The Company recorded a revenue of approximately RMB151 million for the sales of PUYOUHENG (Pucotenlimab Injection), marking a significant increase of 58.8% from the sales recorded in the same period in 2024. In addition, the Group recognized approximately RMB6.3 million in revenue for the provision of CDMO services.During the reporting period, the Company achieved profitability for the first time, with a profit of approximately RMB 29.3 million, marking a turnaround from a loss in the same period of 2024. Net cash generated from operating activities was approximately RMB 46.7 million, and cash and cash equivalents increased to approximately RMB 473 million, representing a positive net operating cash flow compared to the same period in 2024. Research and development expenses amounted to approximately RMB 202 million, representing a decrease of 6.6% compared to the same period in 2024. While ensuring the advancement of core pipelines, cost control measures have shown tangible results.The Company actively develops cooperative relationships with various business channel partners. As of June 30, 2025, the Company completed the tendering process on the procurement platform in 28 provinces of the PRC. We have covered approximately 118 cities in the PRC through various sales channels, and we will further expand our sales network.ADC pipeline enters the critical phase with multiple products, potential for combination therapy highlighted, and fruitful international licensing resultsIn the first half of 2025, the Company remained focused on the research and development of its drug candidates, while continuously assessing market demand and competitive landscape relating to the range of oncology therapeutics and the broad spectrum of indications covered by its drug candidates, in order to maximize the competitiveness of its products pipeline. In particular, MRG003 for NPC nears approval and other key drug candidates advance to pivotal clinical stage.MRG003（EGFR-ADCNPC: MRG003 is under NDA review for the treatment of R/M NPC and has also been granted priority review by the CDE of NMPA. The authority is currently proceeding with the clinical and pharmaceutical evaluation of MRG003. The encouraging data of the pivotal Phase IIb clinical study for the treatment of R/M NPC was read out as “late breaking abstract (LBA)” for oral presentation at the ASCO Congress 2025. The Company is also currently conducting the Phase III clinical trial of combination therapy with MRG003 and pucotenlimab on R/M NPC. The encouraging data in phase II clinical trial of combination therapy on R/M NPC will be presented at the ESMO Congress 2025.HNSCC: As of June 30, 2025, the Company is conducting a randomized, open-label, multicenter Phase III clinical study on HNSCC. In terms of combination therapy with MRG003 and pucotenlimab, we are currently conducting the Phase II clinical trial on HNSCC, and the encouraging data in phase II clinical trial will be presented at the ESMO Congress 2025. The European Medicines Agency (EMA) granted Clinical Trial Authorization (CTA) approvals for the Phase II clinical trial targeting LA-SCCHN in June 2025, and the Company will initiate the clinical trial in the second half of 2025.MRG004A (TF-ADC): The Company has completed the Phase I clinical study on solid tumors in China and the encouraging Phase Ib expansion data on PC will be presented at the ESMO Congress 2025. Protocol communication with CDE for the pivotal clinical trial of MRG004A has been completed, and we have entered the Phase III clinical trial stage in August 2025. In addition, MRG004A was granted BTD by the CDE in August 2025, which offers a brand-new treatment option to patients with pancreatic cancer.MRG006A (GPC3-ADC): MRG006A is a GPC3-targeted ADC with FIC potential globally. We received IND clearance from the FDA in January 2025. We are currently advancing Phase I clinical trial in China. In pre-clinical studies, MRG006A resulted in a robust and dose-dependent tumor growth inhibition on multiple CDX models and HCC PDX models. In the meantime, MRG006A also demonstrated good tolerability in the exploratory toxicology study.MRG007 (CDH17-ADC): We received the IND approval from the NMPA in June 2025 and are currently conducting a Phase Ia clinical trial for the treatment of unresectable locally advanced or metastatic solid tumors. MRG007 has shown robust antitumor activity in preclinical models of GI cancers and a favorable therapeutic index based on IND enabling studies. The pre-clinical data of MRG007 was presented at the AACR Annual Meeting in April 2025. In January 2025, the Company entered into an exclusive licensing agreement with ArriVent, pursuant to which the Company has granted ArriVent exclusive rights to develop, manufacture and commercialize MRG007 outside of Greater China. Under the terms of the agreement, the Company is eligible to receive up to US$1.2 billion in total in upfront payment and development, regulatory and sales milestones, together with tiered royalties on net sales. As of June 30, 2025, the upfront payment has been received.CG0070 (Oncolytic virus): CG0070 was granted BTD by the CDE in January 2025. CG0070 is currently in a MRCT Phase III clinical study conducted by the Company’s U.S. partner, CG Oncology. The latest encouraging data observed has been orally presented in the 120th American Urological Association Annual Meeting in April 2025. The Company has completed the Phase I clinical trial in China and are currently engaged in protocol communication with the CDE regarding the domestic bridging pivotal linical trial.Combination therapy layout: As of June 30, 2025, the Company has completed the Phase II trial of combination therapy with MRG002 and pucotenlimab in the treatment of HER2-expressing solid tumors, which has moved to first-line treatment, and protocol communication for phase III clinical trial has been completed. The Company has observed encouraging data on UC. In terms of combination therapy with MRG003 and pucotenlimab, the Company is currently conducting the Phase II clinical trial on HNSCC, which has moved to first-line treatment, and the encouraging data in phase II clinical trial will be presented at the ESMO Congress 2025. The European Medicines Agency (EMA) granted Clinical Trial Authorization (CTA) approvals for the Phase II clinical trial targeting LA-SCCHN in June 2025, and we will initiate the clinical trial in the second half of 2025, which has been moved up to first-line treatment for advanced disease.Preclinical: Laying the groundwork for innovative platforms and innovative targetsThe Company continuously strives to build up and develop novel technology platforms as innovative engines for the Company. The Company has developed multiple innovative linker-payload platforms for ADC drug candidates, including the Hi-TOPi ADC platform and other early-stage platforms. During the reporting period, our innovative ADC platforms have achieved significant progress. Based on these innovation platforms, the Company has generated two ADC candidates, which are MRG006A with global first-in-class potential and MRG007 with global best-in-class potential, all of which have shown encouraging pre-clinical data and received IND approvals in China. Pre-clinical data of MRG007 was presented at the AACR Annual Meeting in April 2025.On August 1, 2025, the Company entered into a licensing transaction for the license-out and/or transfer of certain intellectual property rights relating to two preclinical assets developed by the Company’s proprietary T cell engager-TOPAbody platform with Excalipoint through entering into the Intellectual Property Assignment and License Agreement.The Company shall receive (i) an upfront payment in cash of US$10 million in aggregate, development and commercial milestone payments in cash of up to US$847.5 million in aggregate and sales royalties, holding a 10% interest, marking international recognition of the platform's value.Future Outlook: Accelerating the Commercialization of Core Products and Advancing Global Strategic DevelopmentIn respect of drug R&D, the Company will further focus on advancing strategic research and development priorities in next generation ADC drugs and IO bi/tri specific antibodies, while accelerating the commercialization of late-stage products. For our registrational stage product MRG003, the relevant authority is currently proceeding with the clinical and pharmaceutical evaluation in an orderly manner. The Company will concentrate our resources and endeavour to expedite the approval process. Meanwhile, our other key drug candidates are entering pivotal clinical stages. Protocol communication for the pivotal clinical trial of MRG004A has been completed, and we have entered the Phase III clinical trial stage in August 2025. In addition, we are currently conducting protocol communication with the CDE regarding the domestic pivotal clinical trial of CG0070. The Company will also explore further potential clinical value of our other innovative drug candidates, such as MRG006A and MRG007. Concurrently, the potential efficacy of combination therapies within our pipeline is being continuously explored, with greater clinical benefits striving to be delivered to a broader patient population.In terms of domestic commercialization, the Company will take further actions to enhance the market accessibility of PUYOUHENG (Pucotenlimab Injection), accelerating market penetration at all levels to further increase market share and enhance the Company's brand image and market recognition. At the same time, the Company will commence the preparation process for the commercial launch of MRG003 and continue to expand our marketing and commercialization teams.On the international front, the Company will ramp up our efforts to expand into the global market. We will expand our international network and explore new business development cooperation opportunities. The Company will remain committed to seeking more strategic partners worldwide to develop our ADC products and other innovative candidates through partnerships, licensing agreements, or joint ventures. Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 20, 2025 - (ACN Newswire via SeaPRwire.com) - In the first half of 2025, the structural transformation of the pharmaceutical industry continued to deepen. Driven by favorable policies, product upgrades, and technological innovation, the vaccine industry maintained a stable and positive growth momentum. As a leading enterprise in China’s innovative vaccine sector, CanSino Biologics Inc.(688185.SH, 6185.HK; CanSinoBIO) once again delivered a solid performance.According to its 2025 interim report, CanSinoBIO achieved revenue of RMB 382 million in the first half, up 26% from a year earlier, extending its growth streak. Although the company has yet to turn profitable, losses have narrowed significantly, with the reduction exceeding 94% compared to the same period last year. This reflects improved operational quality and lays a solid foundation for steady full-year growth. With core products selling strongly and multiple pipeline programs advancing, CanSinoBIO’s long-term growth story is steadily taking shape.Meningococcal Vaccine Portfolio Continues to Scale, Unlocking Growth DriversCanSinoBIO’s two currently marketed meningococcal conjugate vaccines—the quadrivalent meningococcal conjugate vaccine (MCV4, Menhycia) and the bivalent meningococcal conjugate vaccine (MCV2, Menphecia)—remain the company’s key revenue drivers. In particular, the sustained scaling-up of MCV4 demonstrates strong market competitiveness and is central to CanSinoBIO’s growth narrative.In 2024, Menhycia and Menphecia together generated nearly RMB 800 million in sales revenue, representing year-on-year growth of over 40%. In the first half of 2025, driven by deeper channel penetration and higher terminal market coverage, the sales of both vaccines continued to grow steadily. During the same period, the company’s meningococcal vaccine portfolio generated sales of over RMB 364 million, representing more than 38% year-on-year growth and providing a solid foundation for earnings.As the only MCV4 in China, Menhycia effectively covers four meningococcal serogroups, 'ACYW135', and leverages the high-safety CRM197 carrier protein technology. With outstanding clinical immunogenicity and safety, it has become the preferred choice for many parents seeking meningococcal vaccination for their children.Furthermore, Menhycia’s market potential is still being unlocked. The vaccine has been submitted to the National Medical Products Administration (NMPA) for an expanded age indication—from the current “children aged 3 months to 3 years (47 months)” to “children aged 3 months to 6 years (83 months).” If approved, this will directly broaden its coverage, strengthen penetration in the non-national immunization program market, and inject greater certainty into CanSinoBIO’s growth over the next two to three years, further consolidating the company’s leadership in the meningococcal vaccine field.iPneucia Officially Launched, a New Benchmark for Differentiated Pneumococcal VaccineIn June, CanSinoBIO’s self-developed product — the 13-valent pneumococcal conjugate vaccine (PCV13, iPneucia) — was officially approved for market launch, marking the company’s entry into the RMB 10 billion-plus pneumococcal vaccine market and the beginning of a new growth cycle.Pneumococcal diseases remain a serious global public health concern, with particularly high morbidity and mortality rates among children under five years old. Addressing the remaining immunization gaps in China, the launch of iPneucia fills the domestic technological void in high-end 13-valent pneumococcal conjugate vaccines, demonstrating CanSinoBIO’s leadership in differentiated innovation.Compared with existing competing products in the market, iPneucia achieves breakthroughs in three major dimensions. First, it offers more targeted protection, focusing on four high-risk serotypes—19F, 19A, 7F, and 3 - that together account for over 60% of pneumococcal disease cases among Chinese children. Clinical trial data show that its Geometric Mean Concentration (GMC) of antibodies is significantly higher than that of competing products. Second, in carrier protein technology, it adopts the globally pioneering CRM197+TT dual-carrier technology, overcoming the immune interference limitations of single-carrier vaccines. This both reduces the risk of immune suppression when co-administered with other vaccines and significantly enhances immunogenicity. Finally, in manufacturing safety, iPneucia uses an animal component - free fermentation process, reducing risks associated with animal-derived biological factors. It also employs no formaldehyde detoxification and adds no phenol during production, significantly improving vaccine safety.With these three advantages, iPneucia could potentially become another “ace” for CanSinoBIO in the infant bacterial vaccine market, following Menhycia. Notably, iPneucia shares a highly overlapping target population with Menhycia, creating strong channel synergies that will accelerate commercialization and enable the company to quickly capture market share in the RMB 10 billion-plus pneumococcal vaccine segment.Combination Vaccine Strategy Progresses SteadilyBeyond this, CanSinoBIO’s long-term potential lies in its continued build-out of a “Combination Vaccine” portfolio. Compared with traditional monovalent vaccines, multi-conjugate vaccine and polyvalent vaccine can prevent multiple diseases with a single injection, significantly improving vaccination efficiency and willingness - representing a key global direction in vaccine technology development.Following the quadrivalent vaccine Menhycia and multi-valent vaccine iPneucia, CanSinoBIO’s DTcP-Hib-MCV4 pentavalent vaccine—a representative combination vaccine—has attracted strong market attention. In February this year, it received clinical trial approval, marking a “zero-to-one” breakthrough for the company in the high-end combination vaccine sector.The DTcP-Hib-MCV4 pentavalent vaccine can simultaneously prevent pertussis, diphtheria, tetanus, Haemophilus influenzae type b (Hib) disease, and infection by the four meningococcal serogroups (ACYW135), achieving “protection against five diseases with a single shot”. This significantly reduces the number of injections and improves compliance among infants. More importantly, its core component Menhycia has already undergone commercial validation in China and enjoys a strong reputation, providing robust support for the combination vaccine’s development. This “point-to-surface” product upgrade logic enables CanSinoBIO to advance in the combination vaccine market with greater efficiency and confidence. With the government placing high importance on combination vaccine R&D and offering policy support, CanSinoBIO is well-positioned to capture this high-value market.R&D-Driven Growth with a Clear Product Pipeline and Strong ReservesWhile consolidating its existing market advantages, CanSinoBIO continues to strengthen its mid-to-long-term growth momentum through robust R&D capabilities and differentiated pipeline planning.Its DTcP for infants and young children has entered priority review and is expected to fill a domestic market gap. The Tdcp for people aged 6 years old and above has completed Phase III subject enrollment, enabling full life-cycle immunization coverage. The tetanus vaccine’s registration application has been accepted, and it is expected to offer superior safety and immunogenicity data compared with existing products. The Recombinant Poliomyelitis Vaccine, funded by Gates Foundation, has initiated clinical trials in Indonesia and has also received domestic clinical trial approval. Globally innovative Protein Based Pneumococcal Vaccine (PBPV) and inhaled tuberculosis vaccines have entered clinical research and proof-of-concept validation.The company has now built a rich pipeline covering multiple technology platforms and full life-cycle segments, including meningococcal vaccines, pneumococcal vaccines, diphtheria tetanus pertussis vaccine, polio vaccines, tuberculosis vaccines, and zoster vaccine. Several major products are entering critical stages of registration review or clinical trials. Meanwhile, CanSinoBIO’s continuous breakthroughs in key technology platforms support a strategic shift from reliance on single products to sustained pipeline output.Overall, in the first half of 2025, CanSinoBIO maintained the strong growth momentum seen since 2024, proving that its closed-loop capabilities from product R&D to commercialization have become increasingly mature. Against the backdrop of ongoing national policy support for innovative vaccines and domestic high-end vaccine substitution, CanSinoBIO — leveraging its solid R&D foundation, differentiated pipeline layout, and efficient commercialization execution—is accelerating the realization of its long-term growth potential and moving steadily toward becoming a global leader in innovative vaccines.CanSinoBIO, https://www.cansinotech.com [SSE:688185, HKG:6185, OTC:CASBF] Copyright 2025 ACN Newswire via SeaPRwire.com.

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - August 20, 2025) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce that it has entered into an agreement with Red Cloud Securities Inc. ("Red Cloud"), as sole underwriter and bookrunner, pursuant to which Red Cloud has agreed to purchase for resale 5,555,556 units of the Company (each, a "Unit") at a price of C$0.90 per Unit (the "Offering Price") on a "bought deal" basis in a public offering for gross proceeds of approximately C$5,000,000 (the "Underwritten Offering").Each Unit will consist of one common share of the Company (each, a "Unit Share") and one common share purchase warrant (each, a "Warrant"). Each Warrant shall entitle the holder to purchase one common share of the Company (each, a "Warrant Share") at a price of C$1.35 at any time on or before that date which is 36 months after the Closing Date (as herein defined).The Company has granted to the Underwriter an option (the "Over-Allotment Option", and together with the Underwritten Offering, the "Offering"), exercisable, in whole or in part, at any time for a period of up to 30 days after and including the Closing Date, to purchase for resale the number of additional Units equal to up to 15% of the number of Units sold pursuant to the Underwritten Offering at the Offering Price to cover over allotments, if any, and for market stabilization purposes.The net proceeds from the Offering will be used by the Company to fund ongoing operations including, but not limited to, commercial development, product development and working capital.In connection with the Offering, the Company intends to file a prospectus supplement (the "Supplement") to the Company's final short form base shelf prospectus dated March 7, 2025 (the "Shelf Prospectus"), with the securities regulatory authorities in each of the provinces and territories of Canada, except Quebec. The Units may also be sold in the United States on a private placement basis pursuant to one or more exemptions from the registration requirements of the United States Securities Act of 1933, as amended (the "U.S. Securities Act") and in such other jurisdictions outside of Canada and the United States, in each case in accordance with all applicable laws provided that no prospectus, registration statement or similar document is required to be filed in such jurisdiction, and provided the issuance of the Units (including the underlying securities) is permitted under laws applicable to the Company (including the Australian Corporations Act 2001 (Cth).Copies of the Shelf Prospectus and the Supplement to be filed in connection with the Offering can be found on SEDAR+ at www.sedarplus.ca. The Shelf Prospectus contains, and the Supplement will contain, important detailed information about the Company and the Offering. Prospective investors should read the Supplement, the Shelf Prospectus and the other documents the Company has filed on SEDAR+ at www.sedarplus.ca before making an investment decision.The Offering is expected to close on or about September 3rd, 2025 (the "Closing Date"), or on such date as agreed upon between the Company and Red Cloud. The closing of the Offering is subject to the Company receiving all necessary regulatory approvals, including the approval of the TSX Venture Exchange to list, on the Closing Date, the common shares of the Company issuable from the sale of Units as well as upon the exercise of the Warrants.This press release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the U.S. Securities Act, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.About GMGGMG is an Australian-based clean-technology company, which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in-house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low-cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy saving coating), which is now being marketed into other applications, including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed to improve the performance of lithium ion batteries.GMG's 4 critical business objectives are:Produce Graphene and Improve/Scale Cell Production ProcessesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking StatementsThis news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding the expected size and terms of the Offering, the anticipated timing of closing the Offering, the ability of the Company to satisfy all conditions to closing the Offering, and the expected use of proceeds from the Offering.Such forward-looking statements are based on a number of assumptions of management, including, without limitation, expectations and assumptions concerning the business objectives of the Company; the Company's ability to carry out current planned capital projects, research and development, manufacturing, production, sales and marketing programs for its graphene and graphene-enhanced products and solutions; that the Company will receive the necessary regulatory approvals for the Offering; use the proceeds from the Offering as anticipated; the Company's performance and general business and economic conditions.Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: the risk that the Company is not able to use the proceeds from the Offering as anticipated by management; the risk that the Company does not receive the requisite regulatory approvals for the Offering; overall economic conditions; technical de-risking and market acceptance for the Company's products and solutions; the introduction of competing technologies or products; stock market volatility; environmental and regulatory requirements; competitive pressures; change in market conditions and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied in these forward looking statements; the volatility of global capital markets; political instability; the failure of the Company to obtain regulatory approvals, attract and retain skilled personnel; unexpected development and production challenges; unanticipated costs and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated October 3, 2024 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws.NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/263207 Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 20, 2025 - (ACN Newswire via SeaPRwire.com) - Hengdeli Holdings Limited (“Hengdeli” or the “Company” and, together with its subsidiaries, the “Group”; stock code: 3389) announced its interim results for the six months ended 30 June 2025 ("the period under review"). In the first half of 2025, the global environment remained complex and volatile, with uncertainties such as increasing trade barriers, intensifying trade frictions and continuing geopolitical conflicts weighing on the momentum of global economic growth. Under these pressures, China’s economic growth slowed down but maintained stable amidst multiple domestic and external challenges. Still, the country's economy remained resilient as it carried on with steady and sound development. In the face of a complex and volatile operating environment, the Group has adapted its business to market changes by adhering to the principle of “sound, steady and long-term operations” in order to preserve its market position and pursue new opportunities as well as make every effort to safeguard the interests of its shareholders.During the review period, the Group recorded revenue of RMB314,314,000 (six months ended 30 June 2024: RMB580,361,000), representing a year-on-year decrease of 45.8%; high-end consuming accessories business recorded revenue of RMB248,095,000 (six months ended 30 June 2024: RMB352,339,000), representing a year-on-year decrease of 29.6%; commodity trading revenue amounted to RMB66,219,000 (six months ended 30 June 2024: RMB228,022,000), representing a year-on-year decrease of 71.0%. During the period under review, the Group recorded a profit of RMB26,033,000 (six months ended 30 June 2024: profit of RMB499,000), representing a year-on-year increase of 5,117.0%. Profit attributable to equity shareholders amounted to RMB26,308,000 (six months ended 30 June 2024: loss of RMB2,504,000), representing a year-on-year increase of 1,150.6%. The profit was mainly attributable to foreign exchange gains incurred by the operating units as a result of exchange rate fluctuations.During the period under review, in view of uncertainties in the international market and the slowdown in domestic economic growth, the Group’s high-end consuming accessories business continued to face pressure. The Group has taken various measures to cope with the complicated operating environment, and continued to broaden its business models, acquire new customers and develop new products through innovative approaches. At the same time, the Group has enhanced its technological innovation capabilities, accelerated its mechanization, and standardized and strengthened its information and automation management. All these measures have yielded effective results and improved our ability to cope with risks. During the period under review, the sales performance and profit of the high-end consuming accessories business both recorded year-on-year decreases due to the impact of the operating environment.In terms of international trading, during the period under review, the Group continued to carry out the international commodity trading business in line with its established strategy. The business mainly covers the importation of iron ore, thermal coal and coking coal to Mainland China. Global demand for iron ore grew at a slower pace and prices weakened due to dampening economic prospects as a result of trade frictions. Impacted by fluctuating decline in sales prices of ore sand and weakened customer purchasing intentions, the sales and gross profits of the international commodity trading business decreased as compared to the same period last year but still maintained profitability. The Group planned to establish a bulk cargo transshipment logistics park in Mexico integrating customs clearance, import, transportation and warehousing, and has initiated collaborations with and provided services to multiple large-scale enterprises and listed companies in China. In the second half of the year, the Group will continue to keep abreast of market dynamics, promptly and prudently carry out international commodity trading activities and explore new profit models and future development directions, in order to lay a solid foundation for the Group’s sustainable development.In terms of international shipping, during the period under review, the Group’s international shipping business mainly focused on the global maritime transportation of dry bulk cargo, such as coal, iron ore, manganese ore, bauxite, grain and industrial salt. Our clientele includes internationally renowned mining enterprises and large central state-owned enterprises and listed companies in China. During the period under review, the global dry bulk shipping market was volatile, which affected the freight rates. The Group closely monitored the market conditions, continued to expand its business by developing new customers and signing long voyage transportation contracts with its customers to lock in long-term profits for the Company. In the first half of the year, affected by market fluctuations, both the revenue and profit of the Group’s shipping business recorded a decline.At present, the international political and economic environment is experiencing increased turbulence, with trade barriers and trade frictions worsening. Facing this severe external environment, the economy of Mainland China is also encountering difficulties and challenges, including insufficient demand, sluggish consumption awaiting stimulation, and ongoing structural adjustments. Nevertheless, the economy of Mainland China has a stable foundation, strong resilience and great potential, and the long-term positive development trajectory remains unchanged. With the implementation and refinement of various policies and measures by the Chinese government, we maintain full confidence in the long-term sustainable economic growth of Mainland China.In the second half of the year, the Group will adhere to the principle of “sound, steady, and long-term operations”, and will leverage the stable business environment in Mainland China that “pursues stability while seeking progress” to keep abreast of the market trend and further advance the progress of international trade business prudently and steadily. Additionally, the Group will continuously expand the shipping business, which is closely related to international trade, and strive to become an important participant in the international shipping supply chain, so as to provide support for the breakthroughs in corporate development.The Group will also adapt to changing market demands and continuously enhance its integrated service capabilities in commercial space for both Mainland China and international markets. We will adjust the manufacturing of high-end accessories for renowned watches while promoting a limited number of diversified business activities and expanding high-end consuming accessories manufacturing to other high-end lifestyle products, such as jewellery, eyeglasses, cosmetics, mobile phones and other 3C products. Additionally, we will expand our commercial space beautification services to living space beautification services, thus becoming an indispensable and independent segment in the ecological chain of high-end consuming accessories. Copyright 2025 ACN Newswire via SeaPRwire.com.

Novelty and inventiveness confirmed as Focus Graphite moves closer to securing patent for next-generation lithium-ion battery anode materialsOttawa, Ontario--(ACN Newswire via SeaPRwire.com - August 20, 2025) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company") is pleased to provide an update on the status of its patent application entitled "Advanced Anode Materials Comprising Spheroidal Additive-Enhanced Graphite Particles and Process for Making Same" (Canadian patent application No. 3,209,696).The Company reports that no further prior art has been cited in the examination process. The remaining requests for clarification from the examiner are minor in nature, primarily relating to formality issues in the description and figures. Focus is pleased with this outcome and has retained MBM Intellectual Property Law ("MBM") of Ottawa, ON, to prepare and submit claim amendments and expects a positive resolution.In support of its application, Focus has also received the International Preliminary Report on Patentability ("IPRP") issued during the Patent Cooperation Treaty ("PCT"). The IPRP confirmed that the Company's amended claims are both novel and inventive, strengthening the intellectual property protection around Focus' proprietary anode material technology.Additionally, the Company submitted amended claims under the Patent Prosecution Highway ("PPH") for the Canadian case. These amendments, which reduced the number of claims to avoid excess fees, form the basis for the Company's ongoing patent strategy.Dean Hanisch, Chief Executive Officer of Focus Graphite, commented, "This positive progress in our patent application process represents another important milestone in advancing Focus Graphite's downstream strategy. The recognition that our claims are both novel and inventive underscore the uniqueness of our technology and its potential to contribute meaningfully to next-generation lithium-ion battery anode materials."The Company will provide further updates as the application advances.About MBM Intellectual Property LawMBM is an independent, Canadian-owned boutique law firm dedicated exclusively to intellectual property law headquartered in Ottawa. For over 30 years, MBM has provided strategic IP advice and protection for clients ranging from start-ups and universities to multinational corporations. With a diverse team of patent and trademark agents, lawyers, and scientists, MBM manages global patent, trademark, and design portfolios and is recognized for delivering practical, cost-effective solutions. Proudly independent, MBM focuses on building long-term client relationships and maximizing the value of innovation.About Focus Graphite Advanced Materials Inc. Focus Graphite Advanced Materials is redefining the future of critical minerals with two 100% owned world-class graphite projects and cutting-edge battery technology. Our flagship Lac Knife project stands as one of the most advanced high-purity graphite deposits in North America, with a fully completed feasibility study. Lac Knife is set to become a key supplier for the battery, defense, and advanced materials industries.Our Lac Tetepisca project further strengthens our portfolio, with the potential to be one of the largest and highest-purity and grade graphite deposits in North America. At Focus, we go beyond mining - we are pioneering environmentally sustainable processing solutions and innovative battery technologies, including our patent-pending silicon-enhanced spheroidized graphite, designed to enhance battery performance and efficiency.Our commitment to innovation ensures a chemical-free, eco-friendly supply chain from mine to market. Collaboration is at the core of our vision. We actively partner with industry leaders, research institutions, and government agencies to accelerate the commercialization of next-generation graphite materials. As a North American company, we are dedicated to securing a resilient, locally sourced supply of critical minerals - reducing dependence on foreign-controlled markets and driving the transition to a sustainable future.For more information on Focus Graphite Inc. please visit http://www.focusgraphite.comInvestors Contact: Dean HanischCEO, Focus Graphite Inc.dhanisch@focusgraphite.com+1 (613) 612-6060Jason LatkowcerVP Corporate Developmentjlatkowcer@focusgraphite.comCautionary Note Regarding Forward-Looking StatementsCertain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could," "intend," "expect," "believe," "will," "projected," "estimated," and similar expressions, as well as statements relating to matters that are not historical facts, are intended to identify forward-looking information and are based on the Company's current beliefs or assumptions as to the outcome and timing of such future events.In particular, this press release contains forward-looking information regarding, among other things, the anticipated outcome of Focus Graphite's patent application process; the Company's ability to address and resolve the examiner's remaining objections; the expectation of securing patent protection for spheroidal additive-enhanced graphite materials; the potential strategic, commercial, and technological benefits of securing such intellectual property; and the advancement of the Company's downstream strategy to supply advanced graphite materials for lithium-ion batteries in North America and globally.Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, risks related to market conditions, regulatory approvals, changes in economic conditions, the ability to raise sufficient funds on acceptable terms or at all, operational risks associated with mineral exploration and development, and other risks detailed from time to time in the Company's public disclosure documents available under its profile on SEDAR+.The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information.Neither TSX Venture Exchange nor its Regulation Services accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/263193 Copyright 2025 ACN Newswire via SeaPRwire.com.

FINANCIAL HIGHLIGHTS RMB’000 (Unaudited)6 Months Ended June 303 Months Ended June 302025202420252024 Revenue4,645,407 4,610,641 2,307,412 2,473,766 - Office software and services2,657,122 2,413,079 1,355,653 1,187,730 - Online games and others1,988,285 2,197,562 951,759 1,286,036 Gross Profit3,772,214 3,782,688 1,853,628 2,042,035 Operating Profit984,111 1,395,615 382,658 794,037 Profit Attributable to Owners of Parent816,314 677,923 532,440 393,353 Basic Earnings Per Share (RMB)0.60 0.51 0.39 0.29 HONG KONG, Aug 20, 2025 - (ACN Newswire via SeaPRwire.com) - Kingsoft Corporation Limited (“Kingsoft” or the “Company”; HKEx stock code: 03888), a leading Chinese software and Internet service company, has announced its unaudited 2025 interim results and its second quarter results for the period ended 30 June 2025.For the first half of 2025, the revenue of Kingsoft increased by 1% year-on-year to RMB 4,645.4 million. Revenue from the office software and services represented 57% and online games and others represented 43% of total revenue. Gross profit reached RMB 3,772.2 million.For the second quarter of 2025, the Company’s revenue reached RMB 2,307.4 million. Revenue from office software and services and online games and others represented 59% and 41%, respectively, of total revenue for the second quarter of 2025. Gross profit for the second quarter of 2025 was RMB 1,853.6 million.Mr. Jun LEI, Chairman of the Company, commented: “In the second quarter, we advanced core businesses steadily in line with established strategy and firmly positioned for the future. Kingsoft Office focused on ‘AI, collaboration, and internationalization’, continued to strengthen the allocation of R&D resources in related fields, and developed solutions deeply aligned with user scenario needs to sustain competitiveness in the field of intelligent office. The online games business continued advancing content innovation and global expansion, achieving the development of flagship IPs and new game genres.”Mr. Tao ZOU, Chief Executive Officer of the Company, added: “The total revenue for the second quarter amounted to RMB 2,307.4 million, representing a year-on-year decrease of 7%, among which the revenue from the office software and services business was RMB 1,355.7 million, representing a year-on-year increase of 14%. Revenue from the online games and others business was RMB 951.8 million, representing a year-on-year decrease of 26%, primarily due to the high base in the same period last year.”BUSINESS REVIEWOffice Software and ServicesFor the first half of 2025, revenue from the office software and services business increased by 10% year-on-year to RMB 2,657.1 million. The increase was mainly attributable to the growth of WPS individual and WPS 365 businesses of Kingsoft Office. Revenue in the second quarter increased by14% year-on-year to RMB 1,355.7 million.In the second quarter, the office software and services business continued its healthy development. For WPS AI, Kingsoft Office released WPS AI 3.0 and launched the native Office intelligent agent ‘WPS Lingxi’ — the core capability module of WPS AI 3.0. WPS AI 3.0 drove deep integration between AI and office software through bidirectional transformation, achieving native embedding of AI capabilities and deep involvement in office workflows. WPS Lingxi integrated multiple AI functions, marking the transition from tool-based AI applications to collaborative intelligent agents. We also implemented intelligent upgrades to WPS 365 components, and launched messaging, meeting, and email assistants to boost office efficiency.For WPS individual business, Kingsoft Office expanded AI benefits and rolled out new AI products. In overseas markets, we initiated the development of the new WPS International Edition to gradually migrate domestic high-value features. For WPS 365 business, we continuously deepened penetration into industries and scenarios, actively promoted the implementation of AI projects, and engaged in co-creation with key clients to replicate and scale up typical solutions. For WPS software business, we actively participated in the bidding for domestic office software of central and local governments and enterprises. Our products maintained a leading share in both flow layout and fixed layout document software market.Online Games and othersFor the first half of 2025, revenue from online games and others business reached RMB 1,988.3 million, and revenue for the second quarter of 2025 was RMB 951.8 million. In the second quarter, the online games business continued to enrich the brand value of classic JX series and expand into new game genres.During the second quarter, JX3 Online, the flagship IP, maintained engaged player base through consistent content updates and technical optimization. The Fate of Sword: Zero was launched, building upon the core gameplay of the classic JX series IP while introducing innovative explorations. The anime shooter game Snowbreak: Containment Zone sustained its long-term operation, keeping stable user base. The self-developed sci-fi mech game Mecha BREAK commenced its global public beta in July. On its launch day, it topped Steam’s lists for both “Most Played” and “Trending Games,” and earned high scores from several international authoritative gaming outlets like IGN.Additionally, we actively strengthened our collaboration with high-quality overseas IPs, deepening the localized operational capabilities in domestic market. The social deduction game Goose Goose Duck obtained the license approval in June and was expected to launch in the second half of the year. The number of pre-registrations exceeded 5 million, demonstrating its popularity. Cats & Soup: Magic Recipe, the sequel to Cats & Soup, secured its license in May. For the latter half of the year, we will focus on refining the operations of our core titles and continuously optimizing the gaming experience based on players’ feedback.Mr. Jun LEI concluded, “In the coming quarters, Kingsoft Office will continue to increase its R&D investments in AI and collaboration, and promote the implementation of its products and services across a wider range of office scenarios in various industries. The online games business will remain focused on premium games, continue to cultivate its IP franchise, steadily advance its global expansion and achieve long-term operations. We believe that these efforts will strengthen the Group’s core competitiveness and lay a solid foundation to achieve long-term high-quality growth.”About Kingsoft Corporation LimitedKingsoft (3888.HK) is a leading Chinese software and internet service company listed on the Hong Kong Stock Exchange. It has three main subsidiaries: Kingsoft Office, Seasun Holdings and Kingsoft Shiyou. With the implementation of the “transformation toward mobile internet” strategy, Kingsoft has completed a comprehensive transformation in its overall business and management model. The Company has established a strategic layout with office software and interactive entertainment as its pillars, and cloud services and artificial intelligence as its new starting points. Kingsoft has more than 8,000 employees worldwide and holds a significant market share domestically. For more details, please refer to http://www.kingsoft.com.Kingsoft Investor Relations:Li YinanTel: +86 10 6292 7777Email: ir@kingsoft.comFor further queries, please contact Hill and Knowlton:Ovina ZhuTel: +852 2894 6315 Email: kingsofthk@hkstrategies.com Copyright 2025 ACN Newswire via SeaPRwire.com.